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Abstract  
 
The intent of external beam radiotherapy is to deliver as high a radiation dose as possible to 
tumour volume whilst minimizing the dose to surrounding normal tissues. Recent 
development of techniques such as intensity modulated radiation therapy (IMRT) and 
stereotactic ablative body radiotherapy (SABR) aim to extend this capability. The main 
feature of these techniques is to use beams which often contain small fields and very steep 
dose gradients. These present several dosimetric challenges including loss of charge particle 
equilibrium (CPE), partial occlusion of the direct-beam source and steep fall-off in dose in 
the penumbra. Dosimeters which are small in size relative to the radiation field dimensions 
are recommended for such conditions. 
The particular glass beads studied herein have several potentially favourable physical 
characteristics; they are small in size (1 to 3 mm diameter), chemically inert, inexpensive, 
readily available and reusable. The dosimetric characterisation of glass beads has been 
obtained by irradiating them in various radiotherapy beams of kilo-voltage and mega-voltage 
photons, megavoltage electrons, protons and carbon ions. They exhibit minimal fading 
compared with commercial LiF thermo-luminescent (TL) dosimeters, have high TL light 
transparency, high sensitivity and a large dynamic dose range that remains linear from 1 cGy 
to 100 Gy They have also been shown to be independent of dose rate and beam incidence 
angle, as well as having a low variation in response with energy over a range of megavoltage 
photon and electron beams. The latter characteristic is of importance, where spectral changes 
may occur as a function of field size and off axis location and for the use of dosimeters in 
postal audit situations where each institution may have slightly different quality index (QI) 
for their respective photon energies thus ensuring that the calibration is still valid. These 
properties suggest their practical use as TL dosimeters for radiotherapy dosimetry. 
Investigations have been performed to evaluate the feasibility of using glass beads in 
treatment plan verification, small field radiation dosimetry and postal dosimetry audit. 
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1 
 
Introduction  
 
1.1      Motivation  
Recent advances in radiotherapy treatments, such as intensity-modulated radiation therapy 
(IMRT), stereotactic ablative body radiotherapy (SABR) and CyberKnife treatments, demand 
small, high spatial resolution dosimeters (micro-dosimeters) of adequate dynamic range with 
good linearity at high doses of up to 70Gy for quality assurance and clinical application 
purposes. 
While glass jewellery beads are known to exhibit thermoluminescence (TL) properties 
(Zacharias et al., 2008; Moffatt et al., 2012), this medium has not previously been evaluated 
in terms of its potential as a dosimeter for radiotherapy applications. Such dosimeters 
potentially offer excellent spatial resolution (with an effective volume of 1 - 3 mm
3
), low 
cost, reusability, and an inert and robust nature. Furthermore, their spherical shape complete 
with a hole potentially makes for easy positioning in 2- and 3D arrangements, if organised 
along a string, thus allowing one to keep track of the sequence for readout.     
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1.2      Research objectives and scope of the project  
 To characterise the dosimetric properties of glass beads, emphasizing those 
characteristics that are particularly relevant to medical dosimetry of external beam 
radiation therapy dose levels (0.01-100Gy), focusing on the linearity of dose response 
over the entire range, sensitivity, stability, angular and dose-rate dependency, energy 
response, as well as dosimeter response to neutrons.  
 To characterise the above for kilovoltage x-rays, megavoltage photons and electrons, 
as well as the dosimeter response to neutrons. 
 To optimise TLD reader parameters for glass bead TLDs 
 To determine the feasibility of using glass beads for individual patient pre-treatment 
dose verification in complex radiotherapy treatments. 
 To determine the feasibility of the use of glass beads in a national dosimetry audit 
programme 
 To determine the potential of glass bead TL dosimetry in hadron-therapy 
 
1.3      Thesis structure  
Chapter 1: Provides an introduction to the thesis, outlining the motivation and goals of the 
work and details the structure of the thesis.  
Chapter 2: Presents a review of the existing literature and underpinning theory, including 
interactions of different types of radiation (i.e. photons, electrons and protons) with matter, an 
overview of dosimetry in radiotherapy and describes briefly the properties of dosimeters and 
types of commonly available detectors in radiotherapy. 
Chapter 3:  Discusses the preparation procedures for glass bead dosimeters followed by a 
comprehensive characterisation of these for MV photons and accelerated electrons including 
dose response, reproducibility, fading, stability, angular and dose rate dependency, energy 
response over kV and MV photon  and electron energy range, as well as the dosimeter 
response to neutrons.  
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Chapter 4: Focusses on establishing the use of glass beads in small-field dosimetry, 
comparing its performance with Monte Carlo simulations and that of other well-established 
dosimeters for small field dosimetry.  
Chapter 5: Demonstrates patient specific dose verification using glass beads and compares 
the results with current methodology including ionization chamber performance.  
Chapter 6: Investigates the feasibility of using glass beads in a dosimetry audit, evaluated 
within the UK SABR Consortium CIRS dosimetry audit using a CIRS Lung Phantom and 
alanine dosimeters provided by the NPL. The results have been compared with alanine 
dosimetry and the expected dose as calculated from treatment planning systems. 
Chapter 7: Introduces a preliminary investigation of using the glass beads for hadron-
therapy, characterisation of these for protons and carbon ions including dose response, 
reproducibility, dose rate dependency and their applications in beam profile and Bragg Peak 
measurements compared against the standard system of parallel palate ionisation chamber. 
Chapter 8: Conclusions of the research are presented, including suggestions for possible 
future work.  
Published papers, published abstracts and a list of conference presentations and awards 
arising from this research work are attached in Appendix 1.  
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2 
 
Background and context 
 
2.1      Interaction of radiation with matter 
In radiation therapy, the tumour is typically irradiated with photons (x- or γ-rays) or charged 
particles, most commonly electrons and protons, to kill cancer cells or to avoid their spread. 
In the following, an explanation of the interactions of the radiations with matter (tissue) will 
be provided, focusing on photons, accelerated electrons, protons, and carbon ions, being the 
particular radiations of interest in this research.  
 
2.1.1  Interaction of photons with matter 
Photon radiations interacts with matter in various ways; only three of these interaction 
mechanisms can be considered to be of importance for the majority of radiation 
measurements made in radiotherapy (Figure 2.1): the photoelectric effect which is the main 
interaction mechanism for low energy x- and gamma rays (up to several hundred kV), pair 
production, occurs at high energy photons (for tissues, above 5-10 MeV), Compton 
scattering, which is the most probable process over the range of energies between the 
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previous two boundaries, and photonuclear interaction, which occurs at energy photons of 
more than few MV. 
 
Figure 2.1: Relative importance of the three principal interactions of photons with matter 
(Knoll 2000). 
 
2.1.1.1  Photoelectric Absorption  
In the photoelectric absorption process, photons interact with the tightly bound orbital 
electrons of absorber atoms (in the K, L, M, N-orbits). The incident photon is totally 
absorbed by the electron (known as the photoelectron), with the electron being ejected from 
the atom with energy Ee, which can be calculated using the following equation:  
Ee = hν - Eb       Eq. 2.1, 
where: Eb is the binding energy of the photoelectron in its original shell and hν is the energy 
of the incident photon.  
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Figure 2.2: Diagram illustrating the photoelectric absorption process (Khan 2003). 
A vacancy is created in the electron shell as a result of the photoelectron emission. This 
vacancy is quickly filled by capturing a free electron from the medium or rearrangement of 
electrons from other shells of the atom. Consequently, one or more characteristic x-rays 
might be emitted. Auger electrons can also be released, these being mono-energetic electrons 
produced through absorption of characteristic x-rays and subsequent outer-shell electron 
release from the atom.  
Photoelectric absorption is dominant for low energy photon interactions and increases in high 
atomic number, Z, absorber materials. The probability of the photoelectric interactions is 
expressed in the following relation (Khan 2003):  
𝜏
𝜌
 ∝  
𝑍3
ℎ𝑣3
    Eq. 2.2,  
where, 
𝜏
𝜌
 is the mass photoelectric attenuation coefficient and ℎ𝑣 is the energy of the incident 
photon. It is worth mentioning that for low Z elements, i. e. the principal elements of the 
biological world, , 
𝜏
𝜌
∝ 𝑍3.8 (Johns and Cunningham 1983). 
 
2.1.1.2  Compton scattering: 
In the Compton scattering interaction, a photon interacts with a free electron of an absorber. 
The incident photon transfers a part of its energy to the electron and scatters at an angle θ 
with respect to its original direction; the electron receiving a portion of the photon energy is 
referred to as the recoil electron and is emitted at an angle φ. The energy transferred to the 
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electron can have any value from zero up to a large fraction of the incident photon energy; 
the scattering angle of the outgoing photon can be at any angle. The Compton scattering 
process is demonstrated in the following diagram:  
 
Figure 2.3: Diagram demonstrating the Compton scattering process. (Khan 2003). 
 
By using the symbols in the diagram and applying the conservation of energy and momentum 
laws, the scattered photon energy is given by: 
ℎ𝑣′ =  
ℎ𝑣
1+
ℎ𝑣
𝑚0𝑐
2(1−cosθ)
      Eq. 2.3, 
 
where, 𝑚0𝑐
2 is the rest mass energy of the electron, 511 keV.  
Very little energy is transferred from the incident photon when the scattering angle θ is very 
small while the electrons will receive the maximum possible energy from the incident photon 
if the scattering angle is 180°.  
Compton scattering occurs if the energy of the photon is equal to, or exceeds, the binding 
energy of the electron, thus as photon energy increases, photoelectric absorption decreases 
and Compton scattering increases. While the variation in Compton scattering is independent 
of the atomic number Z, the Compton mass attenuation coefficient (σ/ρ), depends on the 
number of electrons per gram. 
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2.1.1.3  Pair production: 
Photons can interact with matter through the pair production mechanism if the energy of the 
incident photon is greater or equal to twice the electron rest-mass energy (511 keV). Figure 
2.4 shows the pair production process. In the pair production process, the photon interacts 
with the electromagnetic field of the atomic nucleus, the photon disappears and two 
electronic particles are created; namely the electron (e
-
) - positron pair (e
+
). Since, the rest 
mass energy of the electron is 0.511 MeV, then 1.022 MeV is the threshold energy for the 
pair production process to take place. For a photon energy that exceeds this threshold energy, 
the excess energy is shared between the two particles as kinetic energy. 
 
Figure 2.4: Diagram demonstrating the pair production process (Khan 2003). 
The positron quickly combines with an electron and two photons with energy 511 keV each, 
emitted in opposite directions, will be produced in a process known as annihilation, as shown 
in figure 2.5. 
 
Figure 2.5: Diagram demonstrating the production of annihilation radiation (Khan 2003). 
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The probability of the pair production interaction depends strongly on the atomic number Z, 
increasing as the square of Z, the pair production mechanism being an interaction with the 
electromagnetic field of an atomic nucleus. Also, it increases as the photon energy increases 
above the threshold energy. 
2.1.1.4  Photonuclear interaction 
The photonuclear interactions occur if the photon energy exceeds the threshold energy, which 
is an inherent nuclear characteristic of each nuclide. As the result of photonuclear 
interactions, secondary radiation, such as neutrons, protons and alphas, are generated. These 
particles are called photoneutrons, photoprotons, and photoalphas. 
2.1.2  Interaction of fast electrons with matter 
Fast electrons interact with the medium through Coulomb interactions with orbital electrons 
and nuclei of medium atoms. This results in loss of energy by two distinct processes, 
ionisational losses with electron interactions (the Bethe equation) and bremsstrahlung with 
nuclear interactions (the Heitler equation). The loss of energy accompanied by a change of 
direction (i.e. scattering) and thus the fast electrons lose their energy at a relatively low rate, 
following a complex path through absorbing materials. In addition, because of electron-
electron interactions large deviations in the electron path are now probable because its mass 
is equal to that of the orbital electrons with which it is interacting, so a much larger fraction 
of its energy can be lost in a single incident. Electrons that interact with orbital electrons or 
the nuclei of atoms undergo elastic or inelastic collisions. In an elastic collision, the incident 
electron changes its direction and is deflected from its original path without loss of energy 
(elastic scattering). Conversely, in an inelastic collision the electron is deflected from its 
original path and in so doing loses some of its energy, the latter being transferred to an orbital 
electron or is otherwise released as an x-ray in the form of a bremsstrahlung photon.  
2.1.3  Interaction of protons with matter 
The interactions between heavy charged particles, such as protons, with matter mainly occur 
through Coulomb forces between the positive charge and the negative charge of the orbital 
electrons within the absorber atoms. As the particle enters the absorber medium, each 
electron of the medium feels the impulse from the attractive Coulomb force as the particles 
passes its surrounding area. This either cause the excitation of the electron to a higher energy 
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shell within the absorber atom or the ionization of the atom by the complete removal of the 
electron from the atom. 
In such an interaction, the charged particle loses energy to the electron and the velocity is 
therefore decreased. The maximum energy Emax that can be transferred from a charged 
particle to an electron is given by equation 2.4: 
     
m
Em
E 0max       Eq. 2.4, 
where E is the kinetic energy of an electron of mass m0, and m is the charged particle mass. 
The maximum energy transfer in an interaction is about 1/500 of the charged particle energy 
per nucleon (Knoll, 2000).  
The charged particle needs many interactions in its way through an absorber in order to lose 
its total energy, after which it stops. The path of the heavy charged particle tends to be 
relatively straight, because they are not greatly deflected by any one collision in their slowing 
down process. Therefore the charged particles are considered to have a definite range, which 
is the distance beyond which no particle will penetrate in a given absorber material.  
The linear stopping power S, also called the specific energy loss, for charged particles in a 
given absorber is defined as the differential energy loss (dE) for that particle within the 
material divided by the corresponding path length (dx): 
    
dx
dE
S       Eq. 2.5, 
The Bethe formula, the classical expression describing the specific energy loss, is written as: 
   NB
vm
ze
dx
dE
2
0
244
      Eq. 2.6, 
where, v and z are the velocity and charge of the primary particle, m0 is the electron rest 
mass, e is the electronic charge, N and Z are the number density and the atomic number of the 
absorber atoms respectively where B is given by equation 2.7 (Knoll, 2000). 
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2.2      Radiation dosimetry in radiotherapy  
A radiation dosimeter is a device, instrument or system that measures or evaluates, either 
directly or indirectly, the quantities of exposure, kerma, absorbed dose or equivalent dose, or 
their time derivatives (rates), or related quantities of ionizing radiation (Izewska and Rajan 
2005).  
In radiotherapy applications, several characteristics are desired for radiation dosimeter 
properties in this context: accuracy and precision, linearity, dose or dose rate dependence, flat 
or known energy response, known or no directional dependence and high spatial resolution. 
Each of these properties are discussed further in chapter 3.  
 
2.2.1  Properties of radiation dosimeters  
Absolute dosimetry: for absolute dosimetry a calibrated detector traceable to a primary 
standard (e.g., NPL primary standard ionisation champers) is required. It is also standard 
practice to follow an established dosimetry protocol or code of practice (such as IPEM CoPs 
and IAEA CoPs). To date, this is commonly practiced with air-filled ionization chambers 
(Wuerfel 2013) in routine hospital practice, although calorimeter or alanine cross calibrated 
detectors may be employed in certain situations. 
Relative dosimetry: refers to the use of a dosimeter’s response in a test situation relative to a 
known situation, e.g., a TL dosimeter that relies on the production of a known reference dose 
as a cross comparison. For relative dosimetry, e.g. dose profile measurement, precision is 
important, the smaller the detector, the more accurate is the characterization of the penumbra. 
If a precise measurement of dose outside of the field is desired, a detector featuring a low 
energy dependence should be chosen. Overestimation of out-of-field and penumbra dose will 
also happen if a relatively large detector is used due to volume effect in the field centre in 
combination with central axis (CAX) normalization. 
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2.2.1.1  Accuracy and precision 
High precision is related to a small standard deviation in the distribution of repeated 
dosimetry measurements, this is also referred to as reproducibility. The accuracy is the 
proximity of the dosimetry measurements’ mean value to the true value.   
 
2.2.1.2  Linearity 
An ideal radiation dosimeter response is directly proportional to the radiation dose (referred 
to as linearity). However depending on the type of dosimeter and its physical characteristics, 
beyond a certain dose range a non-linear behaviour may manifest in both the dosimeter and 
its reader. In such occasions a non-linearity correction may be applied by using a calibration 
curve for the dosimeter. 
 
2.2.1.3  Consistency  
An ideal detector should be stable under various irradiation conditions such as dose rate, 
single radiation or accumulated dose and the thermal and humidity condition. For profile, 
percentage depth dose (PDD) and tissue phantom ratio (TPR) measurements, this is usually 
not a problem but it is important when output factors are measured. To check the detector 
stability, the detector must be cross calibrated periodically.   
 
2.2.1.4  Minimum detection limit 
The detection limit specifies the minimum true value of the measure which can be detected 
with a given probability of error. For low dose applications it is essential that the detector 
measure a value above the background signal.  
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2.2.1.5  Dose rate dependence    
In radiotherapy applications a dosimetric system should be able to measure the integral dose, 
independent of the dose rate. However, in reality the dose rate may influence the dosimeter 
response and may need a correction.  
 
2.2.1.6  Energy dependence 
Ideally, the response of a radiation dosimeter should be consistent and independent of energy 
over the desired range of radiation qualities. However, in reality, for most measurement 
systems, an energy correction needs to be applied.     
 
2.2.1.7  Directional dependence 
The variation in dosimeter response with angle of incident radiation is referred to as 
directional or angular dependence of the dosimeter. Directional dependence can be the results 
of dosimeter construction, physical size and the range and energy of incident radiation 
(Izewska and Rajan 2005). It becomes of importance especially in rotational delivery 
techniques such as VMAT for which the angular independency of the dosimeter is important. 
 
2.2.1.8  Spatial resolution and physical size 
In radiotherapy techniques the dosimetry system should ideally allow point dosimetry or 
integration of a signal over a very small volume.  
 
2.2.1.9  Convenience of use and cost of dosimetry system 
Generally direct reading dosimeters such as ionization chambers are more convenient than 
passive dosimeters i.e., ones that are read after due processing following the exposure (e.g., 
TLDs, films, alanine). However, there are some instances such as postal audits that films and 
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TLDs may be more convenient. It may also be desirable to have dosimeters having both 
integral and differential modes in order to have information about the total dose as well as the 
beam intensity and duration of exposure. 
Ideally the dosimeter should be reusable with no change in its sensitivity within its lifespan 
and be insensitive to handling. Ionization chambers are reusable, with no or little change in 
sensitivity within their lifespan. Semiconductor dosimeters and TLDs are reusable, but some 
types of TLDs gradually loss their sensitivity within their lifespan (typical life span of 
receiving 10,000 Gy (Calandrino et al 1997)) while films, gels and alanine are not reusable. 
Films and gels measure dose distribution in a single exposure. Some dosimeters are very 
sensitive to handling such as films and TLDs while handling will not influence the sensitivity 
of ionization chambers unless it is broken. 
To evaluate the cost effectiveness of a system the labour, equipment and material costs need 
to be considered.     
 
2.2.1.10  Considerations of dosimetry for high LET (charged-particle) 
beams 
For dosimetry of high LET beams, it is important to know about the types of charged 
particles, their fluence spectra and the stopping power, S, of the surrounding absorber 
material and detector at the point of interest. The dose in the tissue may not be proportional to 
the effect observed in a dosimeter. For example: 
 The type of particle and its energy may affect the amount of heat produced in a 
calorimeter and also the production of an ion pair in the gas. 
 The yield of ions in chemical dosimetry depends on the stopping power of the 
particles. 
 If the composition of the dosimeter is heterogeneous it is important to consider 
carefully the transmission delta rays and secondary charged particles across the 
interfaces. 
It is advised (AAPM Report No. 16) to consider two regions for the determination of the 
conversion factors during charged particle dosimetry: 
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1. The plateau, where all the primary particles have approximately the same velocity; 
2. The region in the vicinity of the Bragg peak. 
Hence, to fulfil requirements for charged-particle dosimetry, high resolution stable dosimetry 
systems require linear dose response, independence of dose rate, energy and beam direction, 
stability in a range of thermal and humidity conditions, convenient read out, minimal 
correction and independent of type of radiation (x, , E and ion beams) for practical ease, as 
current dosimetry for charged particles use conversions from photon codes of practice 
(Vatnitsky and Andreo 2002).  
 
2.2.2  Detector types in radiotherapy 
In recent years, technological progress in advanced radiotherapy techniques that use highly-
collimated beams to deliver higher doses to irradiate tumours with high geometric precision 
require detectors that can ensure dosimetric accuracy. This has introduced new challenges 
and consideration for dosimeters in radiotherapy. In particular, when small radiation fields 
are used; there will be a loss of lateral electronic equilibrium and possible volume averaging 
in addition to dose perturbation by the detectors used for their measurement (Aspradakis et al 
2010, Alfonso et al 2008, Das et al 2008, Francescon et al 2008, Scott et al 2008). The 
AAPM Task Group 155 and IPEM Report 103 on small fields and non-equilibrium condition 
photon beam dosimetry have been formed to provide formal guidelines for dosimetry of 
small fields (Das et al., 2014). The IPEM report 103 on small-field MV photon dosimetry 
(Aspradakis et al 2010) recommends the use of detectors with a small volume relative to the 
smallest radiation field under consideration, that exhibit negligible perturbation (Aspradakis 
et al 2010).  
Pappas et al (2008) describe the ideal detector for small-field dosimetry as having the 
following characteristics: water equivalence; a sufficiently small sensitive volume to avoid 
volume averaging; features to enable high positioning accuracy and negligible energy, dose 
rate and directional dependence. However, none of the available radiation detectors fulfil all 
these requirements. In this section, a brief introduction of common radiation detectors used 
for radiotherapy dosimetry is presented considering their application to small field dosimetry, 
treatment planning verification, charged particle dosimetry and use in dosimetry audit. 
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2.2.2.1  Ionization chambers 
Ionization chambers, the recognized standard for large field dosimetry, are affected by 
volume averaging in small fields and in regions of high dose gradient (Aspradakis et al 
2010). Volume averaging causes the detector to underestimate the dose at the centre of the 
beam when the chamber is larger than the uniform region of the beam profile and will include 
dose contributions from penumbral regions. For example, Laub and Wong (2003) reported 
local discrepancies of 10% between calculated profiles and those measured with film in 
regions of steep dose gradient. They attributed this discrepancy to the poor spatial resolution 
of the ionization chamber that was used to collect beam data at the time of commissioning. 
The absolute dose difference was reduced to 2% simply by using a smaller ion chamber.  
Small-size vented air-filled ionization chambers, sometimes referred to as micro-chambers or 
pinpoint chambers, have been manufactured to solve this problem but due to the very small 
volume of less than 0.1 cm³ of these chambers, stem and cable effects, e.g. the polarity effect, 
become more important than for larger ionization chambers, especially when used in a wide 
range of field sizes (IPEM report 103).  
Small liquid ionization chambers allow good spatial resolution and reduced perturbation 
effects. However, some aspects still remain to be addressed, such as the higher recombination 
and the effects from the materials of the detector (Wagner et al., 2013). 
 
2.2.2.2  Semiconductor detectors 
2.2.2.2.1  Silicon diodes 
Silicon diodes are known for their high spatial resolution and small sensitive volume, but are 
compromised by known energy, angular, temperature, and dose rate dependences, which 
need to be rigorously characterized prior to use (Tyler et al., 2013). The density of silicon (ρSi 
= 2.33 g cm
3) is high relative to water (ρwater = 1.00 g cm
3
) and was reported by Scott et al 
(2012) to result in dose perturbation and an over-estimation of dose in small fields. Diode 
over-response has also been reported by many authors (Morin et al 2013, Ralston et al 2012, 
Gagnon et al 2011, Dieterich and Sherouse 2011, Francescon et al 2008, Sauer and Wilbert 
2007, Haryanto et al 2002). Consequently, raw diode readings can only estimate the dose to 
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water if corrections are applied to account for non-water equivalence. These corrections 
relate to field size (Morin et al 2013, Khelashvili et al 2011, Pantelis et al 2010, Francescon et 
al 2008) and depth of measurement (Ralston et al 2012, Eklund and Ahnesj¨o 2010). These 
imperfections are partially attributed to the effects of electron scattering at the metallic parts 
of the shielding and unshielded diodes are introduced in order to overcome these difficulties 
(Griessbach et al 2005). Spherical diodes are newly designed to improve the directional 
dependency (Barbés et al 2014).  
  
2.2.2.2.2  Diamond detectors 
Diamond detectors have been recognized as a potential dosimeter for routine use in advanced 
radiotherapy dosimetry due to the water-equivalence of the construction materials, the high 
signal to noise ratio (Aspradakis et al 2010) and the MV energy-independent response with 
depth (due to relatively constant mass stopping power ratio) (Heydarian et al 1996). 
However, recent studies have reported the energy dependency of diamond detectors 
depending on crystal type or class in addition to that of known dose rate dependency and 
appropriate corrections and determination of dose rate and energy dependency for the 
energies of clinical interest is recommended (Ade et al. 2014).  
 
2.2.2.2.3  MOSFETs 
Metal oxide semiconductor field effect transistors (MOSFETs) are comprised of a 
semiconductor silicon substrate separated from a metal gate by an insulating oxide layer. 
When a MOSFET is irradiated, electron-hole pairs are generated within the oxide layer; the 
electrons move rapidly out of the gate electrode, while the holes move in a stochastic fashion 
towards the Si/SiO2 interface, where they become trapped in long-term sites, which can 
persist for years. MOSFETs can be used for either active or passive dosimetry. In active 
mode, the dose response is linear over a wide range, depending on the oxide thickness and the 
applied bias voltage. The accumulated charge can be annealed under ~150°C, making the 
MOSFET reusable, although recalibration is required following annealing (Rosenfeld 2002). 
They have energy dependency similar to that of diodes, 2-3% source-to-surface distance 
(SSD) dependency, angular dependency of up to 12%, 2–3% temperature dependency in the 
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range 20–37°C (Gopiraj et al. 2008 and Seco et al. 2014). The small size of the dosimetric 
volume, long term storage of accumulated dose, dose-rate independence and ease of readout 
make them suitable for many applications in radiotherapy, such as treatment plan verification 
and in vivo dosimetry. In proton therapy, the use of MOSFETs is currently limited by a large 
LET dependence; the Bragg peak height estimated using MOSFET detectors was shown to be 
almost 40% lower than with an ionization chamber when normalized to the proximal plateau 
(Kohno et al 2006). 
  
2.2.2.3  Thermoluminescent and scintillation detectors 
2.2.2.3.1  Thermo-luminescent detectors (TLDs) 
The TL dosimetry (TLD) system, comprising of a TL medium and a TLD reader, is used for 
the measurement of integrated absorbed radiation dose. Upon irradiation, TL dosimeters store 
a fraction of the resultant absorbed energy in metastable energy levels, the latter being 
presented as electron traps formed from impurities/dopants deliberately introduced into the 
base medium in a highly controlled manner. The irradiation energy stimulates electrons to 
jump to these traps, the model system conventionally being described in terms of a crystalline 
system formed of a valence and conduction band and an intermediary forbidden band in 
which the trapping levels reside. The model is described schematically in figure 2.6. For an 
amorphous system, as in the doped glass system used herein, it is found that the very same 
model can be conveniently used to interpret the functional TL response of such non-
crystalline media. The metastable states are deep enough to prevent escape of the majority of 
electrons at room temperature; however, if the material is then deliberately heated, enough 
energy is given to promote electrons back to the conduction band, where they will 
subsequently recombine with the holes. The energy released by recombination can be emitted 
as optical photons, the associated light yield being indicative of the absorbed dose. 
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Figure 2.6 : Schematic view of TL mechanism (MAESTRO 2014). 
 
A very common TLD is lithium fluoride (LiF) doped with Mg and Ti (LiF:Mg,Ti), which is 
supplied in a range of shapes and sizes, including 1 mm diameter rods and 3.2 mm × 3.2 mm 
‘chips’ with a range of thicknesses and 1 mm3 cubes. The1 mm3 cubes can be used, to a great 
extent, for a point measurement. However, these small commercially available TLDs are very 
sensitive and saturate at dose levels of higher that 10 Gy (Thermo Scientific 2014). LiF TLDs 
are also hygroscopic and hence it is difficult to use them in aqueous environments such as in-
vivo dosimetry, with the exception of surface dose measurements.   
  
2.2.2.3.2  Optically stimulated luminescence (OSL) 
An alternative to TLDs are optically stimulated luminescence dosimeters (OSLDs), being 
highly sensitive (giving large amounts of light output for relatively small absorbed doses) and 
well-suited to personal dosimetry, where carbon-doped aluminium oxide (Al2O3:C) has been 
used for some 15 years. Their principle of operation is very similar to TLDs, except that 
trapped charge is released by controlled illumination instead of heating (Yukihara and 
McKeever 2008). The clinical applications of OSLDs are similar to those for TLDs (Lye et 
al. 2014). 
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2.2.2.3.3  Radiophotoluminescent glass dosimeters.  
Radiophotoluminescent glass dosimeters (RPLGDs), when irradiated, form stable 
luminescence centres, which are able to absorb and release energy. By illuminating the 
RPLGD with an ultraviolet laser, luminescent light is produced. Unlike TLDs, the 
luminescent centres are not destroyed by the readout process, so the devices can be read out 
multiple times to reduce random error. Heating to 400 °C anneals the dosimeter and the 
device can be reused. One complication with RPLGDs is the fact that following irradiation, 
some electrons require additional energy to correctly enter luminescence centres, which can 
be supplied by heating, thus increasing the luminescence signal by up to 50% (build-up 
effect). Preheating before measurement is also recommended to avoid the risk of significant 
uncertainty in fading. Although, they exhibit a small angular dependence (up to 1.5%), the 
low photon energy independence at MV range, high sensitivity and good reproducibility 
make RPLGDs attractive for a range of dosimetry applications, with linearity at a wide range 
from 10 μGy to more than 100 Gy (Rah et al 2009), especially since they are rugged and easy 
to handle. 
 
2.2.2.3.4  Organic and plastic scintillators.  
Organic scintillators are pure crystals composed of aromatic hydrocarbon compounds 
containing benzene ring structures and with decay times of a few nanoseconds. Although 
organic scintillators have fast decay times and are very durable, their response is usually 
anisotropic, they cannot easily be grown into large sizes and are difficult to be machined 
which limits the range of their applications. Plastic scintillators, because of the ease in 
shaping and fabricating, can take the place of organic scintillators. They are produced by 
dissolving an organic scintillator in a solution containing the monomer precursors prior to 
polymerization. Plastic scintillators are available in rods, cylinders and flat sheets, and have 
the advantage of a fairly high light output and a relatively quick signal with decay time of 2–
4 ns. A photomultiplier tube (PMT) is the most commonly used detector for converting 
scintillation photons to electronic signals (Seco et al. 2014). 
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2.2.2.4  Chemical detectors 
2.2.2.4.1  Radio-chromic Films 
Radio-chromic film has been used by several groups for high gradient dose measurements 
(Ralston et al 2012, Gagnon et al 2011, Hsu et al 2011, Hardcastle et al 2011), because it is 
close to being dosimetrically water equivalent, has very high spatial resolution, minimal 
energy dependence (Butson et al 2010), and provides a two-dimensional map of measured 
dose, requiring no chemical processing. However it can have large uncertainties resulting 
from film polarization, non-uniformity as well as scanner and handling techniques (Aland et 
al 2011; Pulmer et al., 2014) in addition to non-linearity of dose response. Despite these 
challenges, radio-chromic film has been recommended for use in small fields (Low et al 
2011, Garc´ıa-Gardu˜no et al 2010, Wilcox and Daskalov 2007). 
 
2.2.2.4.2  Alanine  
Alanine dosimetry is a method based on the generation of radiation-induced radicals in the L-
α–alanine amino acid (CH3-CH(NH2)-COOH). The concentration of stable radiation-induced 
radicals trapped in the crystal structure of alanine is proportional to the absorbed dose over a 
wide range of doses (1–105Gy) (McLaughlin 1993). The concentration of these radicals can 
be estimated quantitatively using electron paramagnetic resonance (EPR) spectrometry. The 
alanine spectrum consists of five spectral lines and the peak-to-peak amplitude of the central 
line is considered to be the dosimetric signal (IOS 1998). The EPR readout is non-destructive 
and multiple reading is possible.  Alanine is a single use, nearly tissue equivalent (ρ ~ 1.2 
gcm
-3
) detector and the accuracy of the system is good, largely due to the low sensitivity of 
the response to irradiation variables (energy, dose rate, temperature, etc.), and the ability of 
EPR spectrometers to measure dosimeter signals very precisely at high doses (≥ 20Gy). The 
disadvantage of alanine is its relatively low sensitivity; therefore, it needs to be irradiated 
with relatively high doses to achieve adequate measurement precision and that is why the 
application of alanine dosimetry to radiotherapy applications is not straightforward, because 
typical radiotherapy doses are at the low end of the working range and, it would take a long 
readout time to produce acceptable results at this dose level (Nagy et al 2002; Azangwe et al., 
2014). The size and shape of the alanine pellets can be customized to fit the experimental 
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requirements, and alanine therefore shows great theoretical potential for small-field 
dosimetry. 
 
2.2.2.4.3  Polymer gels  
A gelatine-matrix-based dosimetry system that avoids the diffusion problem is the polymer 
gel (Maryanski et al 1993). In these inherently three-dimensional dosimetry systems, the 
gelatine matrix contains monomers that polymerize by free-radical induced chain reactions to 
form spatially fixed cross-linked networks. Dose readout can be performed by employing 
MRI, x-ray, ultrasound and optical tomography. X-ray CT has the obvious disadvantage of 
further irradiating the gel, and is very challenging due to very low contrast to noise ratio 
(Seco et al. 2014).  Although MRI is a superior readout technique in comparison with CT and 
Ultrasound, it is still subject to the challenge of obtaining low noise with high spatial 
resolution (Oldham 2015 and Mather et al. 2002). Optical readout is promising, but has the 
disadvantage of requiring optically transparent containers (Doran 2009). Polymer gel 
dosimetry remains the only methods of obtaining fully three-dimensional high resolution 
dosimetry; it is soft tissue equivalent and useful for research and commissioning of complex 
new clinical radiation delivery techniques. Significant care is still required to obtain accurate 
results with batch-to-batch variations in sensitivity affecting most of the currently used 
systems. The reagent batch, thermal history of the gels, container size and post-irradiation 
storage conditions are known factors to influence results. For these reasons gel dosimetry is 
largely limited to relative dosimetry and is not recommended for reference dosimetry use 
(MacDougall et al 2002 and Seco et al. 2014). 
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Characterization of glass beads as 
radiation dosimeters in radiotherapy 
 
Most of the content of this chapter is published in two articles in the journal of Radiation 
Physics and Chemistry: “Jafari, S. M., Bradley, D. A., Gouldstone, C. A., Sharpe, P. H. G., 
Alalawi, A., Jordan, T. J., Clark, C. H., Nisbet, A., Spyrou, N.M. 2014. Low-cost commercial 
glass beads as dosimeters in radiotherapy 97:95–101”, and “Jafari, S.M., Jordan, T.J., 
Hussein, M., Bradley, D.A., Clark, C.H., Nisbet, A., Spyrou, N.M., 2014. Energy response of 
glass bead TLDs irradiated with radiation therapy beams 104: 208–211”. The right to include 
the article in any thesis or dissertation is obtained during assignment of copyright with the 
publisher.  
 
3.1      Introduction  
While glass jewellery beads are known to exhibit TL properties (Zacharias et al., 2008; 
Moffatt et al., 2012), this medium has not previously been evaluated in terms of its potential 
as a dosimeter for radiotherapy applications. Potentially it offers excellent spatial resolution 
(with an effective volume of 1 - 3 mm
3
), low cost, reusability, and an inert and robust nature. 
Furthermore, its spherical shape complete with a hole offers potential for positioning in 2- 
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and 3D arrangements, organised along a string, also allowing one to keep track of the 
sequence for readout.     
In this chapter the dosimetric properties of glass beads are characterised using photon, 
electron, proton and carbon ion beams, emphasizing those characteristics that are particularly 
relevant to medical dosimetry of radiation therapy dose levels (1 cGy – 100 Gy). The focus is 
on the linearity of dose response over the dose range 1 cGy – 100 Gy, sensitivity, the dose 
rate and angular dependency, stability, and response to thermal neutrons. 
 
3.2         Material and 
methods 
3.2.1          Types of beads 
The dosimetric properties of commercially 
produced glass seed beads manufactured by 
Mill Hill (Japan) were studied due to their 
ready availability. Four sizes of beads (1, 2, 
2.5 and 3 mm) in 8 different colours were 
studied. These beads are sold as jewellery 
and in most cases are painted or coated with 
reflective material such as metals (Figure 3.1). 
 
3.2.2          Preparation of glass beads for dosimetry 
3.2.2.1   Cleaning process  
In regard to TL measurements, the coating material will affect the ability of the TL readout 
system to observe the potential luminescence yield of the uncoated media. This could also be 
affected by the annealing process and thereby influence the radiation sensitivity. If EPR 
readout is used for measurements, then the metallic coating can affect the EPR spectra. In 
Figure 3.1: A magnified view of glass beads 
from Mill Hill (Japan) used for investigation 
of their dosimetric properties. 
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order to have a consistent radiation response of the beads it is necessary to remove all the 
paint and coating materials before using them as radiation detectors. It was found that the 
most effective way of cleaning glass beads, to ensure that they were free from paint and 
coating material, was to wash them for 30 minutes in an ultrasonic bath containing a 10-20% 
nitric acid or formic acid solutions. 
 
3.2.2.2    Annealing procedure 
Before exposing the glass beads to radiation, an annealing process was carried out, firstly to 
clear them of any previous irradiation history and secondly to investigate the annealing effect 
on the radiation sensitivity of the glass beads. The dosimetric properties of glass beads can be 
altered by thermal pre-treatment, thermal annealing having the ability to change the defect 
distribution of a TL dosimeter and thereby its sensitivity. An annealing procedure for clinical 
TL dosimetry, used by previous groups to anneal optical fibres (Hashim et al., 2009), was 
applied to the glass beads. Annealing was performed at 400 
o
C for one hour with a ramp rate 
of 10 
o
C per minute and a cooling rate of 1 
o
C per minute. The beads were then subsequently 
kept at 80 
o
C for 16 hours. This annealing procedure was applied upon completion of each 
dosimetric cycle, the dosimetry results showing no change in radiation sensitivity with the 
procedure.   
 
3.2.2.3    Screening for mass 
In order to have homogenous batches of dosimeters to investigate their dosimetric 
characteristics, one thousand 2 mm coloured beads categorised as icy white were screened in 
terms of mass, use being made of an Ohaus Adventurer Analytical balance that was capable 
of detecting down to 0.1mg. The beads were divided according to mass and to within ± 0.2 
mg, in five separate groupings. The group of 9.2 - 9.5 mg were chosen for the present 
investigations, containing about 300 beads. Note that the hole size, allowing the beads to be 
strung together, tends to vary slightly in dimension (0.5 ± 0.1 mm).  
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3.2.3  Readout systems 
In this work it was desired that the dosimeter, in combination with the readout system, could 
provide for accurate determination of commonly applied clinical radiotherapy doses, in the 
range 1 cGy - 100 Gy, in order to evaluate both in-field doses and distant, out of field doses. 
A TOLEDO 654 TLD reader and a Bruker EMX EPR spectrometer were used to study the 
respective TL yield and EPR signal of glass beads, with the intent of identifying the optimum 
choice of readout technique for the identified need. 
 
 3.2.3.1  EPR spectrometer 
The EPR system is of interest as a readout system as it is non-destructive and offers the 
possibility of repeat measurements. It is also able to detect the very deeply trapped electrons 
that can produce a highly stable radiation induced signal whereas there are limitations in this 
regard in a TL system. While such traps require heating above 300° C, most TLD readers do 
not go much beyond this temperature. The EPR measurements were carried out using a 
Bruker EMX X-band EPR spectrometer with a Bruker standard EPR cavity (ST4102) and 
Suprasil quartz tube.  
 
3.2.3.2  TLD reader  
Two TOLEDO 654 TLD readers and one HARSHAW 4500 model TLD reader were 
employed to perform the TL measurements at the University of Surrey and the Royal Surrey 
County Hospital, respectively. 
 
3.2.3.2.1  Readout atmosphere  
Triboluminescence, a phenomenon that does not result from irradiation, may be due to 
exposure to light, with charge transferred from deep traps to the dosimetry traps. It could also 
arise from mechanical effects such as friction, grinding and sieving. It is also known that the 
presence of oxygen can lead to a significant tribosignal. Chemiluminescence is another 
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possibility, resulting from oxidation of the surface or impurities in the sample. Therefore, 
thermoluminescence read out is normally performed in an inert atmosphere (an argon or 
nitrogen atmosphere) (McKeever, 1988). In this work the TL read out was performed in a 
nitrogen atmosphere.  
 
3.2.3.2.2  Dosimetric peak 
For dosimetry purposes, it is desirable for the TL detector to be characterised by a glow curve 
with a peak around 200-250 ºC, the present arrangement allowing for temperatures up to 300 
ºC. The temperature range is sufficiently large to provide for appreciable trap emptying while 
also being sufficiently low for negligible infrared signal from the heated material and cavity 
components (McKeever, 1988).    
In the present study the following parameters were used to obtain the glass bead glow curves; 
preheat temperature of 160 ̊C for 28s; readout temperature of 300 ̊C for 30s and a heating rate 
cycle of 25 ̊C s-1. These settings have been found to produce an optimal glow curve, free of 
the effects of superficial traps. For the glow curve, up to the maximum temperature identified, 
two peaks are observed; the first, much smaller peak, appears just above 135 
o
C while the 
second more dominant peak appears at just above 250 
o
C (Figure 3.2).  
The first peak produced a high and inconsistent fading rate, evaluated by the channel-by-
channel ratio of luminescence obtained at day 2 post irradiation compared to that obtained 30 
days post irradiation. The second peak produced a consistent fading rate, producing a loss in 
signal of some 10% at that peak over the 30 day period. As such, it was apparent that a well-
characterised measurement situation would be obtained by excluding the first peak from 
dosimetric analysis, leaving the shaded section of the glow curve as the dosimetric peak. Also 
shown in Figure 3.2 is a plot of the channel-by-channel fading ratio of the day 2 post-
irradiation luminescence value compared to that obtained 30 days post-irradiation. The glow 
curves for all beads were very similar in terms of peak position while the intensity was 
proportional with bead mass (discussed further in the section 3.6.1.2). 
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Figure 3.2: Glow curve of glass bead showing two dosimetric peaks. The points indicated 
using the dashed line represents the channel-by-channel fading ratio of the day 2 post-
irradiation luminescence value compared to that obtained at 30 days post-irradiation. The 
selected area of the glow curve indicates the peak used for dosimetric analysis. 
 
3.3      Characterization measurements using photon 
beams 
Irradiations were carried out at the Royal Surrey County Hospital using a Varian Clinac 
linear accelerator and at the National Physical Laboratory (NPL) using HotSpot-800 and 
Gammacell-220 
60
Co irradiators. 
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3.3.1  Dose-response and reproducibility 
A 10 × 10 cm2 clinical photon beam of nominal energy 6 MV, produced by the Varian Clinac 
accelerator was used to deliver doses ranging from 1 to 2500 cGy. The dosimeters were 
placed in a water-equivalent phantom (Solid Water®) at 5 cm depth, using a standard Source-
Surface Distance (SSD) of 100 cm.  
To investigate the linearity of radiation response, the mass-screened coloured beads 
categorised as frosted white and icy white were exposed to the 6MV photon beam, delivering 
doses in the range of clinical interest, from 1 – 2500 cGy, at the noted constant dose rate of 
400 MU/min. Four series of measurements were performed for each dose value using the 
same batch of dosimeters. 
To study the TL response versus bead mass, three sizes of icy white beads: 2 mm diameter × 
1.1 mm thickness; 2.5 mm diameter × 1.9 mm thickness; 3 mm diameter × 2.5 mm thickness, 
with respective masses of 3.8 ± 0.7 mg, 9.3 ± 1.2 mg and 59.1 ± 3.1 mg,  were exposed to a 
fixed dose of 10 Gy. Measurements were performed on 10 glass beads from each size 
category and the weight of each glass bead was recorded individually.   
A 
60
Co gamma source was also used to deliver a dose of 25 Gy for EPR measurements of a 
selection of the beads, specifically those beads possessing intrinsic colour. The 
reproducibility of the system response was tested by performing three consecutive linac 
irradiations of 11 Gy, using a constant dose rate of 400 MU/min.   
 
3.3.2  Dose rate setting dependence 
The dose rate setting dependence was tested by delivering a constant dose of 2 Gy using 
different set dose rates, from 100 - 600 MU/min. Measurements were repeated three times for 
each dose rate value. 
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3.3.3  Angular dependence 
The angular dependence of dosimeters was tested by positioning the mass screened frosted 
white beads in a Perspex phantom at angles of 90°, 45° and 0° from the bead axis (Figure 
3.3). A radiation dose of 2 Gy was given using 6 MV photons and a 10 ×10 cm2 field at a 
gantry angle of 0°.   
 
3.4      Energy response of glass bead TLDs irradiated 
with radiation therapy beams 
Energy response is one of the main characteristics that must be known for a TL material in 
order for it to be used in any radiation dosimetry application (Oberhofer and Scharmann, 
1981). The energy dependence of a dosimeter can be defined as the dosimeter reading per 
unit of absorbed dose to water for a given radiation beam relative to that for a reference beam 
quality (in this work 6 MV photons). For radiotherapy applications, it is desirable that a 
dosimetry system suffer no practical change in energy response over the range of clinical 
beam qualities. The investigated glass beads are not (soft) tissue equivalent. The aim of this 
section is to investigate the energy dependence of this form of glass bead across the range of 
beam energies produced by a clinical linear accelerator and an orthovoltage radiotherapy unit. 
 
Bead axis 
45°   0°           90° 
(a) (b) 
Figure 3.3: (a), positioning the beads in a Perspex phantom at angles of 45°, 90° and 0° from 
the bead axis. (b), schematic drawing of bead axis. Coloured glass beads have been shown, 
allowing a clear view of the object 
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3.4.1  Materials and methods 
3.4.1.1  Glass beads 
A batch of glass beads (Stock#: G42010, Size: 15/0 (2 mm), Mill Hill, Japan) was prepared 
for dosimetry. Prior to use, the glass beads were prepared as in the section 3.2.2.  
 
3.4.1.2  Elemental analysis of glass beads 
3.4.1.2.1  Energy Dispersive X-ray (EDX) analysis 
The composition of the particular glass beads studied has not been specified by the 
manufacturer.  Qualitative/quantitative sample analysis was therefore performed, using an 
Energy Dispersive X-ray (EDX) unit coupled to a HITACHI S3200N Scanning Electron 
Microscope (SEM) located in the Faculty of Engineering and Physical Science at the 
University of Surrey (figure 3.4(a)). The EDX unit provides X-ray fluorescence spectroscopy 
capability. The glass beads were attached to a stainless steel sample holder and were coated 
with gold to inhibit electrostatic charge build-up during investigation (figure 3.4(b)). The 
scanning process was performed over the surface area of the glass beads. An Oxford 
Instruments INCA Imaging System was used to identify the elemental composition. The 
software automatically identifies the peaks in the X-ray spectrum and, from this, the elements 
in the sample with the quantity of each element is calculated automatically.  
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3.4.1.2.2  Micro-PIXE analysis of glass beads 
(a) 
(b) 
Figure 3.4: (a), the EDX unit coupled to a HITACHI S3200N Scanning Electron 
Microscope (SEM). (b), the glass beads attached to a stainless steel sample holder and 
coated with gold to inhibit electrostatic charge build-up during investigation. 
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The University of Surrey houses the Engineering and Physical Sciences Research Council 
national ion beam facility. The micro-beam facility used herein is based on a 3MeV 
Tandetron™ accelerator, described in detail by Simon et al. (2004). Further to the EDX 
analysis, a micro-beam proton-induced X-ray emission (PIXE)/Rutherford Back Scattering 
(RBS) analysis technique was also utilised for the glass beads elemental analysis. Although 
PIXE is an expensive technique, the key advantages of the PIXE method, other than its 
generally non-destructive nature, are the availability of simultaneous multi-elemental 
analysis, a fairly short data collection time and the very low background, avoiding primary 
bremsstrahlung production, with parts per million detection limits.  
The samples were irradiated on the micro-beam line in a beam of 3 MeV protons with a spot 
size of 2 × 2 μm, and measured using a copper grid and a proton current of between 0.3–0.8 
nA. The sample holder (figure 3.5(b)) was mounted inside the target chamber, which was 
designed to include a moving sample stage and can be used for simultaneous PIXE and RBS 
analysis. The characteristic X-ray photon emissions were detected using a SGX Si–Li 
detector (Sensortech Ltd, High Wycombe, UK) of 80 mm
2
 active area and 140 eV energy 
resolution at 5.9 keV, mounted at a scattering angle of 45° to the beam. In order to reduce the 
(a) (b) 
Pieces of glass beads 
Figure 3.5: (a), the micro-beam facility. (b), the sample holder and pieces of different colour 
glass beads glued on that.  
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intensity of the Si Kα X-rays and to avoid spectrum degradation by high energy recoiling 
protons, the Si–Li detector was fitted with a two-layer absorber consisting of 130 μm 
beryllium foil and 50 μm Kapton foil. Scanning was carried out over the cross-sectional area 
of the glass beads glued on the holder, producing a pixel-by-pixel map of the sample 
elemental composition. For each sample, elemental maps were collected for localisation, and 
then, an area was set up in order to obtain the elemental concentrations.  
 The elemental composition of glass beads (colour code; clear) obtained using EDX is given 
in table 3.1 and the results of PIXE analysis is given in table 3.2. It is worth mentioning that 
the discrepancies between EDX and PIXE results can be justified by considering the depth of 
measuerment point. EDX is a superficial analysis while the information with PIXE analysis is 
from a slightly deeper volume, typically 100 micron with a 3 MeV proton beam. Therefore, 
the presence of the element C in the EDX data could possibly be due to carbon contamination 
during sample preparation and also from the oil in the vacuum chamber. Similarly the Al 
could be due to the use of aluminium wire to hold the glass beads together during 
preparation. Iron (Fe) is also present in the PIXE report, however, in a much smaller quantity 
of 7 parts per million (ppm) (table 3.3).   
 
Table 3.1: the elemental composition of glass beads obtained using the EDX technique 
Element Weight% Atomic% 
C  8.93 14.38 
O  42.18 51.01 
Na  10.55 8.88 
Al  1.35 0.97 
Si  33.62 23.16 
K  1.09 0.54 
Ca 1.92 0.93 
Fe  0.37 0.13 
Totals 100.00 100.00 
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Table 3.2: the elemental composition of glass beads obtained using the PIXE/RBS technique. 
Element Weight% Atomic% 
O 53.18 65.70 
Na 10.07 9.05 
Si 33.30 23.51 
K 1.14 0.60 
Ca 2.30 1.14 
Total 100 100 
 
Rare elements with weight % of less than 1% that are detected by PIXE analysis and do not 
have a significant effect on the effective atomic number of the material but can play an 
important role in TL properties of glass beads are reported in ppm (table 3.3).    
 
Table 3.3: Rare elements detected by PIXE analysis. 
Element Cl  Fe  Zn  Sn  Sb  P  S  Sn  Sb  Pb  
ppm 882 171 607 835 1043 4443 499 433 1981 1362 
 
Figure 3.6 shows PIXE imaging. It is evident that all of the elements are distributed 
homogenously in the glass beads. 
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3.4.1.3  Effective atomic number of glass beads 
The effective atomic number of the glass beads was calculated to be 10.6 and 10.7 using both 
elemental composition data of EDX and PIXE techniques respectively with the well-
established formula (3.1) (Khan 2003). 
  (3.1) 
where 
 is the fraction of the total number of electrons associated with each element, and 
 is the atomic number of each element. 
  
The % difference between both techniques was calculated to be 0.9%. 
 
Figure 3.6: PIXE imaging, (a), 
Homogenous elemental distribution 
in the glass beads that is shown for 
the elements Si, Ca and K as 
examples. (b), a magnified picture 
of snapped glass bead to enable a 
deeper elemental analysis. The 
circle shows the area that analysis 
was performed.  
 
(a) 
(b) 
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3.4.1.4  Variation in mass X-ray attenuation coefficients for the glass 
beads 
The mass attenuation coefficient, μ/ρ, as a function of photon energy for the glass beads, was 
calculated, using both EDX and PIXE analysis data, within the energy range 1 keV to 20 
MeV, use being made of the XCOM program provided by the National Institute of Standards 
and Technology (NIST) (Berger et al. 1990, 1998) and plotted against those of cortical bone, 
B-100 bone-equivalent plastic, soft tissue and the dosimetric materials, air, LiF and alanine 
(Figure 3.7).   
 
Figure 3.7: Calculated mass attenuation coefficients, obtained using the XCOM program 
provided by the National Institute of Standards and Technology (NIST) (Berger et al. 1990, 
1998). In the low energy regime, from a few keV to 100 keV, the highly Z dependent 
photoeffect dominating, it is apparent that the glass beads closely match the mass attenuation 
coefficients of NIST B-100 Bone Equivalent Plastic. From 100 keV to 10 MeV, with the 
reduced energy dependence of Compton scattering events dominating, there is more general 
accord between the various media. 
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3.4.1.5  Density of glass beads 
Within the radiotherapy energy range, Compton interactions play a major role in photon 
energy attenuation, being linearly dependent on the atomic number and the electron density 
of the attenuator. The density of the glass beads has been obtained by two independent 
methods as follows, the first being a measure of the electron density and the second the 
Archimedean density: 
(i) Using a computerised tomography (CT) scanner, CT scans were performed with a head 
and neck protocol (due to window of Hounsfield Units were used in this protocol) using 
the GE Lightspeed RT/16 CT scanner for a slice thickness of 1.25 mm and a pitch of 1. 
Images were acquired using a matrix of 512×512 pixels. The CT Number of the glass 
beads was found to be within the range of 800-1300 ± 13, overlapping with the cortical 
bone CT Number obtained using the same CT scanner, namely 900-1350; 
(ii) Using the water displacement method, the density of the glass beads was found to be 2.09 
± 0.01 g/cm
3
. This can be compared with the density of cortical bone, reported to be 1.92 
g/cm
3
 (ICRU44). 
 
3.4.1.6  Glass bead TLD insert 
For the MV photon and MeV electron irradiations a water-equivalent phantom made up of 
Solid Water® slabs has been used. One of the slabs comes complete with a cavity in which a 
graphite walled cylindrical ionization chamber type NE2571 can be introduced. However, in 
the present work a custom made plastic (Polyetheretherketone (PEEK) material) insert to 
hold the glass bead TLDs (Figure 3.8) has been employed, the shape of the insert mimicking 
that of the ionisation chamber. 
 
(a) 
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Figure 3.8: (a) Custom made insert to hold glass bead TLDs, (b) Schematic of the Farmer ion 
chamber shaped insert, sizes are in mm. 
 
3.4.1.7  TLD reader 
For this part of work, the Harshaw 4500 planchet TLD reader was employed to readout the 
TLDs. The reading setup was as explained in section 3.2.2. 
 
3.4.1.8  Irradiation procedures 
The glass bead TLDs were irradiated at a reference depth (dmax) in a water equivalent epoxy 
resin phantom (Solid Water®) with a standard setup where the absolute dose to water is 
known for the given beam quality. The beam quality index (TPR20/10) for MV photons is 
defined as the relative dose at depths of 20 cm and 10 cm in water for a constant focus to 
detector distance of 100 cm according to international Dosimetry Codes of Practice (e.g. 
IPSM 1990, IAEA 2000), and for electron beams is the depth at which the dose reduces to 
50% of the maximum value (R50,D in cm) according to the Code of Practice for high-energy 
electron dosimetry (IPEM 2003).  
Measurements were performed using 92 glass bead TLDs (8 beads were irradiated for each 
MV photon- and electron-beam energy, 5 beads for each kV range energy and 13 beads were 
kept as a control group). All irradiations were performed on the same day with at least 24 
hours being allowed to elapse before read-out. The irradiation and measurement was repeated 
for the 6 MV photon beam reference beam quality (TPR20/10 = 0.670). The energy 
dependence of the dosimeter was then calculated by obtaining the ratio of the dosimeter 
response at the given beam quality to the response of the dosimeter at the reference beam 
quality. 
(b) 
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3.4.1.8.1   Irradiations with the 6 to 15 MV photons 
A 10 × 10 cm field size for clinical photon beams of 6 MV (TPR20/10 = 0.670), 10 MV 
(TPR20/10 = 0.738) and 15 MV (TPR20/10 = 0.761), produced by a Varian Clinac linear 
accelerator, was used to deliver a dose of 2 Gy using a standard Focus-Surface Distance 
(FSD) of 100 cm. The holder containing the dosimeters was placed in a water-equivalent 
phantom (Solid Water®) at the restrictive depths 1.5, 2.5 and 3 cm, using thicknesses of 
available phantom slabs. The dosimeter readings were corrected to the 100% dose at dmax, for 
each nominal beam energy. 
 
3.4.1.8.2   Irradiations with the 6 to 20 MeV electrons 
A standard 10 × 10 cm electron applicator was used for electron beam measurements to 
deliver a dose of 2 Gy for 6 MeV (R50,D = 2.4 cm), 9 MeV (R50,D = 3.65 cm), 12 MeV (R50,D = 
5.1 cm), 16 MeV (R50,D = 6.7 cm) and 20 MeV (R50,D = 8.35 cm) energies. The holder 
assembly was placed in the same water-equivalent phantom as before, at a depth of 1.5 cm 
for the 6 MeV beam, 2 cm for the 9 MeV beam and 3 cm for the remaining energies. 
Dosimeter readings for the 9 MeV measurements were corrected to dmax.  
 
3.4.1.8.3  Irradiations with the 80 to 250 kV photons 
The kV photon irradiations were performed on a Gulmay clinical orthovoltage X-ray 
generator. The glass bead TLDs were placed on the surface of a 30 × 30 × 6 cm Solid Water 
slab and standard output setups for each nominal beam energy were used to deliver a dose of 
2 Gy at 80, 140 and 250 kV with HVLs of 2.4 mm Al, 6.2 mm Al and 2.7 mm Cu 
respectively. For 80 and 140 kV the standard applicator has an 8 cm diameter and 30 cm length 
whereas for 250 kV the standard is a 10 × 10 cm, 50 cm long applicator.  
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3.5      Results and discussion  
3.5.1  Radiation Response 
3.5.1.1  Bead colour and radiation response  
Both the TL yield and EPR signal were observed to vary with bead intrinsic colour (Figure 
3.9), due in part to the different dopants involved in creation of the various glass colours, 
modified in the case of TL by self-absorption of light within the beads. This is supported by 
the EPR results, showing relatively high radiation induced signals for dark coloured beads 
compared to the TL yield. One of the aims of the present study has been to detect doses of the 
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Figure 3.9: Radiation response for different coloured beads with the two readout systems 
used herein. 
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order of cGy (the interest being in dose evaluation to healthy tissues surrounding a tumour 
treated by radiotherapy), a matter satisfied in the TL study by the frosted white, icy white and 
light bronze coloured beads. A choice has subsequently been made to limit further TL 
characterisation studies herein to the white coloured beads, which provide an indication of the 
capabilities offered by this more sensitive group of beads.  
In the EPR study, a radiation induced signal was observed for all intrinsically coloured beads 
except those with blue and green colours. The latter showed distorted signals, possibly due to 
paramagnet metallic impurities. Excluding the latter, and focusing on measurements made 
using 2 mm beads, the EPR spectrometer nevertheless provided a low signal to noise ratio for 
doses lower than 10 Gy for all of the other coloured beads. Further investigation is required 
to examine the lower limit of detection for the larger bead sizes, which also suggests an 
investigation of the use of an EPR glass bead system for very high dose measurements, as in 
sterilization doses.  
 
3.5.1.2  Bead mass and radiation response 
For a fixed dose of 10 Gy, the TL response versus bead mass for icy white beads was 
observed to be linear with respect to mass for the three bead sizes (Figure 3.10): 2 mm 
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Figure 3.10: TL response as a function of glass bead mass. 
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diameter × 1.1 mm thickness; 2.5 mm diameter × 1.9 mm thickness; 3 mm diameter × 2.5 
mm thickness, with respective masses of 3.8 ± 0.7 mg, 9.3 ± 1.2 mg and 59.1 ± 3.1 mg.  
 
3.5.2  Batch homogeneity and reproducibility  
The response of a batch of mass-screened icy white dosimeters exposed to a uniform dose of 
10 Gy varied by ± 7.4 % (2 SD), whereas the mean individual reproducibility for 138 
dosimeters, pre-readout annealed at 140 degrees C for 28 sec, evaluated with a manual 
planchet TOLEDO 654 TLD reader, was found to be 0.23% (2 SD). The latter result appears 
promising when compared against the mean individual reproducibility of TLD-100 micro-
cubes similarly exposed, of 0.61% (1 SD) (Rossa et al. 1999). The combined standard 
deviation of the entire TLD process for the 138 bead dosimeters was measured to be 1.7%, 
being within the range of 1.7 to 2.3% reported by the IAEA/WHO TLD postal programme 
(Izewska and Andreo 2000). The results for the batch of dosimeters and the individual 
dosimeter response reproducibility are shown in Figure 3.11.  
The reproducibility of each individual dosimeter was found to depend on the stability of the 
TLD reader output as well as consistency of the position of beads on the planchet and 
annealing procedure. The TLD reader output was found to be the main source of variability, 
of the order of 3%, for the same batch of beads, during the course of a day of use for all three 
TLD readers that were monitored. In regard to sample positioning, a central location with the 
hole through the bead located perpendicularly to the planchet was found to provide the most 
consistent results, offering even-heating. This resulted in reproducibility to within ± 1.7% for 
the 138 samples investigated.  Given that the planchettes used for the current work were 
designed for 10 mm and 5 mm TLD-100 dosimeters it would seem that a custom designed 
planchet could improve upon current reproducibility. It is worth mentioning that the dopant 
content of glass bead TLDs may vary from batch to batch and for different manufacturers. 
Therefore, it is suggested that for the safe application in radiotherapy, the suitability of each 
batch of glass beads must be determined on a case-by case basis. 
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Figure 3.11: TL yield of a group of mass-screened icy white glass beads, irradiated to 6 MV 
photons at a fixed dose of 10 Gy. The experiment was repeated to check the reproducibility. 
× indicates results from a first round of irradiations; ■ indicates results from a second round 
of irradiations. Note that in general a good degree of reproducibility is obtained but that there 
are individual beads demonstrating a wider degree of discord.  
 
3.5.3  Linearity  
For mass-screened frosted white and icy white samples exposed to 6 MV photons delivering  
doses of clinical interest, from 1cGy to 25 Gy, a linear response with an R
2
 correlation 
coefficient of  > 0.999 was observed (Figure 3.12(a) and (b)). These results represent a large 
step forward when compared with the TLD-700 types which were used in an IAEA/WHO 
TLD postal programme, with non-linearity being reported to be the dominant source of 
uncertainty (Izewska and Andreo 2000).  The reproducibility was checked by 4 sets of 
measurements irradiated on the same day using the same batch. 
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Figure 3.12: Radiation response of (a) icy white and (b) frosted white beads over the dose 
range of 0.01 – 25 Gy, irradiated using 6 MV photons. The error bars represent the 
uncertainty on the slope. 
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3.5.4  Dose rate setting dependence  
The response of glass beads to set dose rates in the range 100-600 cGy/min, encompassing 
the typical dose-rates delivered in external beam radiotherapy using linear-accelerators, were 
found to be within ±1% (Figure 3.13) confirming MU/min setting independency for these 
dosimeters. This independency is of considerable advantage for pulsed radiation dosimetry as 
provided by a  linear accelerator.  
 
Figure 3.13: TL response of glass beads irradiated with the same dose delivered at different 
dose rates of 100 - 600 cGy/min, using 6 MV photons. 
 
The dose-rate independence of glass beads along with the linear response over a wide range 
of doses is of considerable advantage compared to many other forms of dosimeter, typically 
showing saturation effects due to elevated ionization density when high LET beams are used 
at higher dose rates (Nadrowitz et al 2012). 
 
3.5.5  Angular dependence   
The response of the glass beads to different angles of irradiation using photon beams was 
found to be within 1% and thus independent of beam angle (figure 3.14). This is 
advantageous compared to other dosimeters of small size, such as diodes and diamond 
detectors, for which angular response is a problem (Araki et al., 2003; Araki et al., 2004; 
Heydarian et al., 1996).  
7750
7950
8150
8350
8550
0 100 200 300 400 500 600
T
L
 Y
ei
ld
 (
n
C
) 
Dose Rate (cGy/min) 
 64 
 
 
 
Figure 3.14: response of glass beads when irradiated at 0°, 45° and 90°, using 
photons.  
 
3.5.6  Storage and handling  
3.5.6.1  Light exposure  
As with other TL materials, the glass beads were also found to be sensitive to light, both after 
annealing and also subsequent to irradiation. After annealing, the background reading from 
the beads has been observed to increase as a result of exposure to light (Figure 3.15), this is 
an important point to consider in seeking to measure low doses, as in for instance at the level 
of cGy.  
The post-irradiation fading effect was also reduced by storing samples in the dark (such as a 
black plastic box). The fading rate was found to be 10% for the integrated TL dosimetric 
peak as well as the EPR signal following first 30 days storage at room temperature under 
darkened conditions (Figure 3.2 and 3.16) that mainly occurred at the first 24 hours. For long 
term, 23% fading is observed for 2 years post-irradiation for dose range of 1 cGy to 25 Gy 
(Figure 3.17). These results are promising when compared with 28 day fading rates of 25-
60% for commercially available LiF and CaSO4 based TLDs (Harvey et al. 2010).  
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Figure 3.15: Sensitivity of samples to light subsequent to annealing.  
 
Figure 3.16: Fading effect for glass beads measured by EPR signal.  
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Figure 3.17: long term fading effect of TL signal for glass beads, measured 2 years post 
irradiation. 
 
3.5.6.2  Reading Planchet  
Consistency of positioning the glass beads on 
the planchet and the smooth and reflective 
surface of the planchet were found to be two 
very important factors while performing 
reading of a transparent glass bead TLD using 
a planchet; as can be seen in figure 3.18. The 
planchet is designed for common TLDs such 
as TLD 100 with a size of 10 mm diameter 
which is much bigger than the size of a glass 
bead TLD, therefore, it is crucial to always 
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place the glass beads at the centre of the planchet with its axis perpendicular to the surface. A 
scratched surface of a planchet in addition to any metallic colour change could change the 
reflection properties of the planchet. When a darkened planchet was exchanged with a new 
shiny one, a difference of 12% was seen in readout. Therefore, for a transparent TL material 
such as glass beads a planchet made up of a metal resistant to colour change and scratch 
resistant is needed.  
 
3.5.6.3  Consistency check 
It has been known since the early applications of TLD materials that the radiation and 
thermal history have an effect on the sensitivity of TLDs (Folkard et al 1987). The response 
of the same batch of glass beads after being exposed to different dose levels and reused up to 
8 times are plotted in graphs 3.19 (a) and (b).  
 
Comparing these results with findings in the report from Folkard et al on TLD-100 (Figure 
3.20), the glass beads seems much more stable than TLD-100s. However, the results show 
that for high precision dosimetry, all glass bead TLDs from a batch must be treated together. 
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Figure 3.19: (a), The sensitivity change as a function of number of annealing cycle and (b) 
dose history. Each data point is average readings of 20 glass beads and the errror bars 
represent the standard deviation of these 20 glass beads response.  
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Figure 3.20: (a), Sensitivity change in TLD-100 as a function of annealing history and (b), 
dose history reported by Folkard et al (1987). The open symbols are X-ray data and full 
symbols are 
137
Cs data. 
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3.5.7  Energy response 
Figure 3.21 shows the TL response obtained for kV X-rays and MV photon and MeV 
electron irradiations.  
 
Figure 3.21: TL response of glass bead TLDs irradiated to a dose of 2 Gy with kV X-rays, 
MeV electrons and MV photons respectively. The inset provides an enlarged view, showing 
the TL yield variation for the MeV electrons and MV photons. 
 
3.5.7.1  Response to the 6 to 15 MV photons 
For the megavoltage photon beams, the experimental findings show a decrease in glass bead 
TLD response from unity (the normalised value) at 6 MV to 0.98 ± 0.01 and 0.96 ± 0.02 for 
the 10 and 15 MV X-ray beams respectively (Figure 3.21). These modest changes in energy 
response are in line with the variation in experimental results reported for other dosimeters, 
with an energy dependency which is some 1% greater compared with alanine using EPR 
dosimetry and similar to lithium fluoride (Waldeland and Malinen, 2011; Yaakob et al., 
2011) over the similar range of energies.  
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3.5.7.2  Response to the 6 to 20 MeV electrons 
The energy response of glass beads at 6, 9, 12, 16 and 20 MeV nominal electron beam energy 
compared with 6 MV photons normalised to unity was found to be 0.98 ± 0.02, 0.97 ± 0.01, 
0.98 ± 0.01, 0.97 ± 0.01 and 0.95 ± 0.01 respectively (Figure 3.21). In comparison with 
published data, these results demonstrate that the energy response of the glass beads to 
electron beams is similar to that of alanine using EPR dosimetry. However, unlike lithium 
fluoride, which is reported to have an increase in response with the higher electron beam 
energies (Waldeland  and Malinen, 2011), the glass bead TLDs show a slight decrease in 
response with energy.  
 
3.5.7.3  Response to the 80 to 250 kV photons 
The mean energy response of the glass bead TLDs for the X-rays generated at 80, 140 and 
250 kV was found to be respectively 4.5 ± 0.05, 3.8 ± 0.04 and 1.7 ± 0.02 times greater than 
that for unity at 6 MV photons (Figure 3.21), also approaching 3 times that of LiF TLDs and 
5 times that of alanine (Waldeland and Malinen, 2011). The greater energy dependence of 
glass bead TLDs in this lower energy range can be explained by the non-soft tissue 
equivalence of glass as the photoelectric process is the dominant interaction for relatively low 
energy X-rays (Knoll 2010). This is made apparent in Figure 3.21. While in this same energy 
range the evaluation of dose to soft tissue could be hampered by the energy dependency of 
the glass beads, the glass bead TLDs could be used to evaluate dose to bony tissue. This is 
further supported by the results of the CT scan of the glass beads, showing CT numbers that 
are similar to that of cortical bone. 
The significant energy dependency of the glass bead TLDs in the kV range point to a 
potential for energy discrimination of the incident photons if these glass beads are used in 
conjunction with another TLD type such as TLD 100. The most popular method of energy 
discrimination to date has been the fitting of metallic filters, with an associated potential 
source of ± 30% error in dose assessment (Kalmykov, 1994). However, further investigation 
is required if use is to be made of the sensitivity ratios of the two TL materials as an indicator 
of incident photon energy. 
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3.6      Conclusions 
In this work, a number of positive dosimetric properties have been demonstrated for 
commercially available MILL Hill glass jewellery beads for radiotherapy applications 
involving a range of modalities. TL and EPR systems were employed for glass beads readout 
and TL system satisfied the requirement for the detection of doses of the order of cGy in 
addition to that it is accessible and the easier to use. The glass beads were characterised by 
investigating their radiation sensitivity, linearity with dose, fading rate, energy response, 
angular and dose rate independency. These results demonstrate the potential for use of glass 
beads as TL dosimeters over the photon and electron dose range commonly applied in 
radiotherapy with special care in the range of kV energy. However, the glass beads 
dosimetric characterizations are subject to material composition and glass beads of different 
brands must be characterized individually. 
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4 
 
Performance of glass beads in small 
field photon dosimetry 
 
The content of this chapter is published in the journal Physics in Medicine and Biology: 
“Jafari S. M., Alalawi Amani I., Hussein M., Alsaleh W., Najem M. A., Bradley D.A., 
Spyrou N.M., Clark C.H., Nisbet A.,
 
2014.
 
Glass beads and Ge-doped optical fibres as 
thermoluminescence dosimeters for small field photon dosimetry, 59: 6875-6889. The right 
to include the article in any thesis or dissertation is obtained during assignment of copyright 
with the publisher.  
 
4.1      Introduction 
Recent developments in external beam radiotherapy techniques using small field photon 
beams, such as intensity modulated radiation therapy (IMRT) and stereotactic ablative body 
radiotherapy (SABR), present several dosimetric challenges including loss of charge particle 
equilibrium (CPE) (Attix, 1986; Nahum, 1996; Zhu, 2010), partial occlusion of the direct-
beam source (Zhu and Bjarngard, 1994; Sharpe et al., 1995; Zhu and Bjarngard, 1995; Zhu et 
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al., 1995; Hundertmark et al., 2011; Tyler et al. 2013), and steep fall-off in dose in the 
penumbra of small fields (Rice et al., 1987; Crop et al. 2009). Dosimeters which are small in 
size relative to the radiation field dimensions are recommended for such conditions 
(Bjarngard et al., 1990; Higgins et al., 1995; Francescon et al., 1998; Sauer and Wilbert, 
2007; Aspradakis et al., 2010; Hundertmark et al., 2011). Therefore, an ideal detector for 
small-field dosimetry should have the following characteristics: water equivalence; a 
sufficiently small sensitive volume to avoid volume averaging; features to enable high 
positioning accuracy and negligible energy, dose rate and directional dependence (Pappas et 
al 2008). 
The particular glass beads used herein and compared against well-established optical fibres 
have several potentially favourable physical characteristics as dosimeters in small field 
conditions. Both are small in size (1.5 mm diameter and 1 mm thickness for the glass beads 
and 5 mm length and approximately 120 μm diameter for the optical fibre (figure. 4.1 (a) and 
(b)), chemically inert, inexpensive, readily available and reusable.  
                            
 
It has been found (in earlier chapters and Bradley et al. 2012) that both glass beads and 
optical fibres exhibit minimal fading, have high thermoluminescence (TL) light transparency, 
high sensitivity and a large dynamic dose range that remains linear from 1 cGy to 25 Gy (i. e. 
the investigated range of doses). They have also been shown to be independent of dose rate 
and beam incidence angle; the results agreed within 1% when both TL materials were 
irradiated with the same dose at different angles. However, the optical fibres (Bradley et al., 
2012) have a greater energy dependence; for photon beams, an approximate 6% decrease is 
observed between the TL yield obtained at 6 and 15 MV photons and decreasing by 40% in 
comparing the TL yield at 20 MeV electrons. The energy response is considered of relevance 
Figure 4.1: A magnified view of (a) a glass bead (hollow, with 0.5 mm internal diameter) 
and (b) 5 mm lengths of optical fibre. For illustration purposes only, a coloured glass bead 
has been shown, allowing a clear view of the object. 
(b) (b) 
1.5 mm 
1
 m
m
 
(a) 
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in the current study, where spectral changes may occur as a function of field size and off axis 
location and this may affect the accuracy of measurement of profiles and field widths if a 
variation in response with energy were present. It is also important for the use of dosimeters 
in postal audit situations where each institution may have slightly different quality index (QI) 
for their respective photon energies thus ensuring that the calibration still be considered valid. 
These properties suggest their practical use as TL dosimeters for small field radiotherapy 
dosimetry. 
This part of study has investigated the feasibility of using glass beads and Ge-doped SiO2 
optical fibres for small field photon beam TL dosimetry, with measurements being compared 
against those obtained using well-established dosimeters including EBT3 Gafchromic film 
and a commercial 2D ionisation chamber (IC) array. Measurements from optical fibres and 
EBT3 Gafchromic film were jointly performed with Miss Amani Alalawi and measurements 
from 2D ionisation chamber (IC) array were performed by Mr Mohammad Hussein (two 
other PhD students). Measurements from all dosimeters were benchmarked against Monte-
Carlo (MC) simulation obtained using the BEAMnrc/ DOSXYZnrc code widely considered 
as the gold standard MC simulation code for radiotherapy applications (Rogers et al., 1994). 
It is worth noting that other well-established TLD materials, such as 1 mm
3
 LiF: Mg, Ti 
cubes have an upper range dose limitation of 10 Gy and therefore are not suitable for 
comparison across the full dose range examined in this work where the glass beads and 
optical fibres were tested in a ranges of doses from 1cGy – 25 Gy. 
 
4.2      Material and methods 
4.2.1  Detectors 
4.2.1.1  Glass beads  
A batch of clear glass beads, 1.5 mm diameter and 1 mm thick outer shell (Petite: Stock#: 
G42010, Mill Hill, Japan) with material composition (by weight): C-8.93%, O-42.18%, Na-
10.55%, Al-1.3%, Si-33.62%, K-1.09%, Ca-1.92%, Fe-0.37% (section 3.5.1.2) was selected 
for this work. Prior to use, the glass beads were prepared as in the previous chapter. Glass 
beads of mass 3.4 ± 0.1 mg were calibrated using a 6 MV clinical photon beam (TPR20/10 = 
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0.670) with a field size of 10 × 10 cm
2
. For the 6 MV photon beam, the machine is calibrated 
to give 1 cGy dose for 1 MU at 1.5 cm depth for a field size of 10 × 10 cm
2
 and SSD 100 cm. 
A Harshaw 4500 planchet TLD reader was employed to readout the glass beads. To avoid the 
more rapid early fading in TL signal that is commonly exhibited in TL materials, readings 
were only obtained following a post-irradiation delay of at least 24 h to allow stabilisation of 
the TL signal. Using the present system, the readout cycle initiates when the planchet 
achieves a temperature of 160 ºC, followed by heating to a maximum of 300 ºC at a ramp-rate 
of 35 ºC/s. Glow curves of glass bead and optical fibre is plotted in figure 4.2 in comparison 
with TLD-100 (LiF:Mg, Ti). 
 
Figure 4.2: The glow curve of irradiated glass bead, Ge-doped optical fibre and TLD-100 
obtained using a Toledo TL reader. 
 
4.2.1.2  GeO2 doped SiO2 optical fibres 
GeO2 doped SiO2 fibres (CorActive, Canada) with a 50 μm doped core diameter and a 
cladding diameter of 124.7 ± 0.1 μm were used. Prior to irradiation, the outer cladding was 
removed using a fibre stripper (Miller, USA). The fibres were then cut into lengths of 0.5 ± 
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0.1 cm with a mass of 4.55 ± 0.9 μg. 0.5cm fibres were considered a practical choice of 
length for ease of handling and to minimise the risk of displacement by nitrogen gas flow 
during the readout process in the TLD reader. The gross TL yield was normalised to unit 
mass to mitigate against uncertainty in TL yield due to variations in the cut lengths. The 
fibres were then irradiated with a fixed dose and a batch selected to provide a dose response 
to within ± 1% of the group mean (Bradley et al., 2007). The optical fibre TL yield was 
measured using a Toledo TL reader (Pitman Instruments, Weybridge, UK) 24 h post-
irradiation. The parameters used in providing for an optimum glow curve (Figure 4.2), were a 
preheat temperature of 160 ºC for 10 seconds and a readout temperature of 300 ºC for 25 
seconds at a ramp rate of 35 ºC /s, in accord with previous practice for this material (Bradley 
et al., 2007).  
 
4.2.1.3  Gafchromic film EBT3 
Gafchromic® EBT3 20 × 25.4 cm
2
 film sheets were used. Measurements were performed in 30 
× 30 cm
2
 Solid-Water
® 
phantom slabs (Gammex Inc., Middleton, WI). The orientation of the 
film was consistent for all measurements; with each film marked to allow consistency in 
setup and readout. All Gafchromic films were processed and analysed at least 48 h after 
exposure, to account for any post-irradiation coloration effects. Films were scanned using the 
Epson Espression 10,000 XL flatbed (Seiko Epson Corp., Nagano, Japan) colour scanner at a 
resolution of 72 dpi, using the red channel. The Gafchromic film batch was calibrated for a 
range of doses between 0 and 2800 cGy. The IBA OmniPro-I’mRT v.7.0 software was used 
for analysis. 
 
4.2.1.4  2D ionisation chamber (IC) array  
The OCTAVIUS Detector 1000SRS is a commercial 2D-Array that has been developed for 
dosimetric verification of small fields. The 2D-Array consists of a matrix of 977 liquid-filled 
ion chambers with 2.3 mm   2.3 mm   0.5 mm volume and 2.5 mm centre-to-centre detector 
spacing in the central 5 5 cm2 area and 5 mm in the outer 10   10 cm2 area. The detectors 
within the 2D-Array had a relative uniformity calibration against the central detector set at 
the factory. The nominal effective point of measurement (EPOM) is located at 0.9 cm from 
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the surface. Characterisation measurements were performed on a Varian Clinac iX at 6MV 
according to the methodology previously described by Poppe et al (2013) and results were in 
agreement with published data. The array was calibrated for absolute dose to water through 
inter-comparison against an NE2571 type ionization chamber in solid water (Gammex, UK). 
To achieve this, the array was set up such that the EPOM was at 5 cm from the solid water 
surface. A 10   10cm2 field size was used, at 100cm FSD to the surface of the solid water 
and beam was delivered for 100 cGy at 400 cGy/min. The ionisation chamber was set up in 
similar conditions using the same type of solid water. The absolute dose to water calibration 
factor, ND,W array, was derived as follows: 
𝑁𝐷,𝑊 𝑎𝑟𝑟𝑎𝑦 =
𝑅𝑖𝑜𝑛 𝑐ℎ𝑎𝑚×𝑁𝐷,𝑊 𝑖𝑜𝑛 𝑐ℎ𝑎𝑚×𝐹𝑇,𝑃×𝐹𝑖𝑜𝑛
𝑅𝑎𝑟𝑟𝑎𝑦
   (4.1) 
Where Rion cham was the average of at least 4 ionisation chamber readings, ND,W Ion cham was the 
absolute dose to water calibration factor for the ionisation chamber, FT,P was the temperature 
and pressure correction for the ionisation chamber, and Fion was the ion recombination 
correction for the ionisation chamber. Rarray is the average of 4 readings measured by the 
central detector in the 2D array. Note that no temperature and pressure correction was 
required as the array was not vented to the atmosphere and that equation (4.1) was such that 
ND,W array was set to include ion recombination correction, since all measurements were 
performed at a fixed dose rate. 
The PTW Verisoft software (version 5.1) was used in this study to acquire and analyse 
measurements.  
 
4.2.2  Phantoms  
Two custom jigs were constructed of Solid-Water
® 
phantom plates (30 × 30 × 1 cm
3
) 
(Gammex, UK) with superficial indentations to locate the glass beads and optical fibres in an 
indented line such that the detectors centre-to-centre distance was 2 mm. Additional slabs of 
Solid-Water
® 
were used above and below the dosimeter arrangements to provide for depth-
dose measurements with full scatter conditions. 
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4.2.3  Irradiation procedures 
All dosimeters were irradiated with 6 MV photons (TPR20/10 = 0.670) from a Varian Clinac 
2300iX accelerator (Varian Medical Systems, Palo Alto, CA). For the relative output factor, 
irradiations of 12 Gy dose at 5 cm depth were delivered using a standard Focus-Surface 
Distance (FSD) of 100 cm, for each field size sequentially: 10 × 10 cm
2
, 4 × 4 cm
2
, 3 × 3 
cm
2
, 2 × 2 cm
2
, 1 × 1 cm
2
, the field sizes being defined at the phantom surface. The 
irradiations were performed first to the 2D-array. Then, without changing the field size, the 
glass beads, film and optical fibres (that were sandwiched between solid water phantom 
slabs) were irradiated together in a single irradiation. The positions of dosimeters were such 
that the film was placed on top of the plate which was holding the glass beads and the jig 
holding the optical fibres was placed on top of the film (Figure 4.3). In this arrangement the 
glass beads, film and optical fibres were approximately 1 mm centre to centre apart in depth. 
The field divergence over this distance was considered to have a negligible effect on the field 
size measurements. The detectors’ shadowing effect was also ignored due to the very small 
thickness of optical fibre (124.7 ± 0.1 μm) and approximate tissue equivalency of the film.  
 
 
4.2.4  Monte Carlo simulations  
An EGSnrc v.4 / BEAMnrc Monte-Carlo (MC) code (Kawrakow 2000, Rogers et al 2001) 
was used to model a generic linear accelerator head of a Varian Clinac based on geometries 
and material data provided by the manufacturer for the 2100C - 2300iX Clinac model (for 6 
MV X-rays (TPR 20/10 = 0.670)). This model of the linear accelerator was used for the 
2 mm 
Optical fibres Film 
Glass beads 
Solid water 
Solid water 
(a) 
(b) 
Figure 4.3: (a) irradiation setup, and (b) a schematic view of 
the detectors assembly.  
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measurements within this study and the beam quality and field size settings over the course of 
this study were confirmed as being consistent with original commissioning data. Validation 
of this simulated linear accelerator head was performed by matching and comparing the 
values of Monte-Carlo calculated and measured depth dose distributions of a standard 10 × 
10 cm
2
 radiation field (Ding 2003) and a 4 × 4 cm
2 
field size, the smallest available field size 
for which commissioning data was available. The entire accelerator head and a water 
phantom were the only adjustable parameters in the beam simulation. The simulated data 
were compared with measured data obtained during the photon beam commissioning of this 
accelerator, using an ionisation chamber, RK-018 (Wellhofer Dosimetrie, Germany) with 
effective volume 0.12 cc and active length 10 mm. 
Monte-Carlo calculations were performed in a 40   40   40 cm
3
 water phantom. The score 
region was a multi layered water cylinder with voxel sizes of 1 mm radius and varying 
heights between 2 mm for superficial measurement points to 10 mm for greater depths 
centred along the beam central axis with a focus-to surface distance (FSD) of 100 cm from 
the centre of the target. The lower energy threshold for electron transport (ECUT) and the 
lower energy threshold for photon transport (PCUT) were chosen to be 0.521 MeV and 0.01 
MeV respectively. Sufficient particle histories were simulated so that the statistical 
uncertainty of the Monte Carlo calculations was maintained at less than 1%. 
The BEAMnrc/ DOSXYZnrc code (Kawrakow, 2009; Alexander, et Al., 2011) was then used 
for beam profile calculations by using the input file of the previously mentioned simulated 
linear accelerator head. The BEAMnrc/ DOSXYZnrc simulation was validated by comparing 
and matching the values of Monte-Carlo calculated and measured beam profile parameters 
such as the full width at half maximum (FWHM) and penumbra of a 10 × 10 cm
2
 and a 4   4 
cm
2
 radiation field that were obtained by using a photon diode (SCANDITRONIX, F1356, 
Wellhofer Dosimetrie, Germany) with an effective detection area of 2.5 ± 0.1 mm and 
effective detection thickness of 60 μm. 107 histories were used for the simulation. ECUT (the 
lower energy threshold for electron transport) and PCUT (the lower energy threshold for 
photon transport) values were 0.521 MeV and 0.01 MeV, respectively. The voxel dimensions 
in the xy-plane were 1 mm for all field sizes around the central axis (CAX). 
The above models were accepted when the difference between simulated and measured data 
points were within 2% (figures 4.4 and 4.5).  
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Figure 4.4: Percentage depth doses at 6 MV in the 10 × 10 cm
2
 and 4 × 4 cm
2
 field 
calculated with EGS4nrc/BEAMnrc and BEAMnrc/ DOSXYZnrc Monte Carlo simulation 
codes and compared with measured data by ionisation chamber. 
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Figure 4.5: Beam profiles at 5 cm depth at 6 MV in a 10 × 10 cm
2
 field calculated with 
BEAMnrc/ DOSXYZnrc Monte Carlo simulation code and compared with measured data 
obtained with a photon diode. 
 
4.2.5  Analysis of results 
Given the ideal characteristics for a small field detectors and the absence of a universally 
acceptable dosimeter fulfilling all of the above criteria for small-field measurements, the 
Monte Carlo DOSXYZnrc was taken to be the reference for the analysis of the results in this 
study. The MC calculations are frequently used as a detector-independent reference (Tyler et 
al. 2013) as Monte Carlo is calculating absorbed dose to water, therefore there is no concern 
about detector/water effects when considering the ratios to determine output factors. The 
Gafchromic film and the high-resolution 2D-array of liquid-filled ionisation chambers, as 
well established detectors, were used to cross-check the consistency of results. The relative 
performance of all detectors was therefore quantified as a deviation from MC simulation 
result.   
A comparison was made between measured and calculated output factors and profiles 
parameters: the FWHM of the measured profiles using each dosimeter and the penumbral 
width as the distance between the 80% and 20% dose and also between the 90% and 10% 
dose (Leonard, et al., 2007, 2000), being compared with those generated by MC calculation.  
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The uncertainties reported in this study are based on multiple measurements of the same dose 
using each dosimeter in a 10 × 10 cm
2
 reference field size (type A uncertainties) which 
include setup variations, dosimeter reproducibility and beam output variations. For the small 
field sizes one measurement for each data point was taken using each dosimeter. The 
uncertainty budgets (2 SD, i.e. 95% confidence level) for the glass beads and optical fibres 
are presented in table 4.1.  
Table 4.1: The uncertainty budgets for the glass beads and optical fibres 
Source of uncertainty  Relative 
standard 
uncertainty (%) 
for the glass 
beads (2 SD) 
Relative 
standard 
uncertainty (%) 
for the optical 
fibres (2 SD) 
Positioning of glass beads and optical fibres  0.3 0.3 
The uncertainty in the primary standard calibration* 1.0 1.0 
Uncertainty in dosimeter calibration 1.3 1.3 
Harshaw 4500 planchet TLD reader output  2.0  
Toledo TL reader output  3.3 
Standard deviation of the TLDs (one vs the other) 2.7 3.8 
Calculated standard uncertainty )quadratic 
summation)  
3.8 5.3 
   *IAEA technical reports series no. 469          
The values presented in table 4.1 are based on the QA measurements for the linear accelerator 
and the TLD readers used. Standard deviations of the TLDs are derived from the response of 
dosimeters to the same dose. The reproducibility of each individual TLD was found to 
depend on the stability of the TLD reader output as well as consistency in the positioning of 
beads and fibres on the planchet and annealing procedure (see chapter 3).  
The total uncertainty for the 2D array was 2.3% and was determined from stability of the 2D 
array readings (0.2%), calibration uncertainty (0.7%), dose linearity uncertainty (0.2%) and 
effective point of measurement (EPOM) uncertainty (2.2% (reported by manufacturer)). 
Using film, the total uncertainty on expected dose determination due to the calibration curve 
fitting was 3.2% measured for all field sizes which is slightly higher than values of 2.8% and 
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2.5% uncertainty reported by Aland et al. (2011), and Ralston et al. (2012) respectively. This 
might be due to the fact that Gafchromic film is affected by manufacturing inhomogeneities, 
and by the scanning and calibration processes. Higher uncertainty of ± 8.7% in dose 
determination have also been quoted in the literature (Hartmann et al., 2010). The average 
local film uniformity was found to be within 1.8% for unexposed as well as exposed films 
with the scanner uniformity of 0.7% keeping the same orientation of the film on the flat bed.  
 
4.3      Results  
4.3.1  Relative dosimetric parameters 
4.3.1.1  Relative Output factors 
Relative output factors were obtained for each field size, defined as the detector response for 
the particular field size at a FSD of 100 cm at 5 cm depth in water and normalized to the 
detector response at 5 cm depth in water for a 10 × 10 cm
2
 field size defined at the surface. 
The output factors and the % differences of measured results with the DOSXYZnrc MC 
simulation are given in table 4.2.  
Table 4.2: Output factors for the different systems 
Field size (cm) 4 × 4 3 × 3 2 × 2 1 × 1 
MC DOSXYZ 0.90 0.88 0.85 0.75 
2D-array Ionisation Chamber  0.91 0.88 0.85 0.78 
    % Difference from MC 0.9 0.0 0.0 4.0 
Gafchromic film 0.88 0.86 0.78 0.55 
    % Difference from MC -2.0 -2.6 -8.0 -26.1 
Glass Bead  0.91 0.87 0.85 0.73 
    % Difference from MC 1.5 -1.3 0.0 -2.3 
Optical fibre  0.93 0.86 0.82 0.66 
    % Difference from MC 3.4 -2.4 -3.5 -11.6 
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4.3.1.2  Beam profiles 
Beam profiles were measured at a depth of 5 cm and an FSD of 100 cm. All beam profile 
measurements were normalised to the dose at the central axis for a 10 × 10 cm
2
 field size 
defined at the surface (figure 4.6). The beam field size accuracy on the machine was 
confirmed by standard QA procedures performed at the time of these measurements and on a 
regular monthly basis to be within 1.3%. 
 
Figure 4.6: Profiles acquired with the BEAMnrc/ DOSXYZnrc Monte Carlo simulation code 
(MC), Gafchromic film (GF), ionization chamber (IC), glass beads (GB) and optical fibre 
(OF) for the 10 × 10 cm
2
, 4 × 4 cm
2
,  3 × 3 cm
2
, 2 × 2 cm
2
 and 1 × 1 cm
2
 field sizes at 5 cm 
depth in water and normalised to the dose at the central axis for a 10 × 10 cm
2
 field size. 
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 To evaluate the agreement between the detectors, the FWHM and penumbra were considered 
(figure 4.7).  
  
 
 
Figure 4.7: FWHMs (↔) and penumbras (beam fall off points between the 80% and 20% 
(‹∙∙∙∙∙∙∙›) and also 90% and 10% (‹----›)) are measured parameters for the 10 × 10 cm2 (a and 
b), 4 × 4 cm
2
 (c), 3 × 3 cm
2
 (d), 2 × 2 cm
2
 (e) and 1 × 1 cm
2
 (f) field size at 5 cm depth in 
water.  
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The results for FWHM and penumbras are shown in table 4.3. Since the measurements were 
performed at 5 cm depth at 100 cm FSD, the FWHMs for the 10 × 10, 4 × 4, 3 × 3, 2 × 2 and 
1 × 1 cm
2
 fields were expected to be 105.0, 42.0, 31.5, 21.0 and 10.5 mm respectively. The 
2D-Array used in here is designed for the measurement of small radiation field sizes thus data 
points was limited to the areas smaller than 10 × 10 cm
2
 and therefore, there is no opportunity 
to measure penumbra 90 – 10.  
Table 4.3: Field widths and penumbras measured with the three detectors and a MC 
simulation at 5 cm depth. The DOSXYZnrc MC simulation is taken as the reference value. 
 
FWHM 
(mm) 
% 
difference 
of FWHM 
Penumbra 
90-10 (mm) 
Difference  of 
Penumbra 
90-10 (mm) 
Penumbra 
80-20 (mm) 
Difference of 
Penumbra 
80-20 (mm) 
10×10 cm
2
 
Monte Carlo 104.3  10.4  4.5  
Gafchromic 
Film 
104.2 -0.1 9.9 -0.5 4.1 -0.5 
2D-Array 104.2 -0.1   4.3 -0.3 
Glass Bead 104.9 0.6 11.3 0.9 4.8 0.3 
Optical Fibre 104.1 -0.2 10.7 0.6 5.8 1.3 
4×4 cm
2
 
Monte Carlo 41.9  7.2  3.9  
Gafchromic 
Film 
41.9 0.0 7.7 0.5 3.7 -0.2 
2D-Array 42.0 0.2 6.9 -0.3 4.0 0.1 
Glass Bead 42.0 0.2 7.8 0.6 4.2 0.3 
Optical Fibre 42.2 0.6 7.6 0.4 3.9 0.0 
3×3 cm
2
 
Monte Carlo 31.3  5.8  3.2  
Gafchromic 
Film 
31.4 0.5 6.6 0.7 3.4 0.2 
2D-Array 31.5 0.8 6.5 0.6 3.8 0.6 
Glass Bead 31.5 0.8 6.9 1.1 3.9 0.6 
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Optical Fibre 30.8 -1.5 5.9 0.0 3.1 -0.1 
2×2 cm
2
 
Monte Carlo 21.0  5.4  3.0  
Gafchromic 
Film 
21.0 0.0 5.8 0.4 3.1 0.0 
2D-Array 20.9 -0.6 6.0 0.6 3.8 0.7 
Glass Bead 20.9 -0.4 6.8 1.4 3.7 0.6 
Optical Fibre 20.7 -1.4 5.1 -0.3 3.1 0.1 
1×1 cm
2
 
Monte Carlo 10.4  4.6  2.8  
Gafchromic 
Film 
10.8 3.8 4.2 -0.5 2.5 -0.3 
2D-Array 10.6 1.6 4.8 0.2 3.6 0.8 
Glass Bead 10.4 -0.7 5.3 0.7 3.2 0.5 
Optical Fibre 10.6 1.5 4.1 -0.6 2.9 0.1 
 
 
4.4      Discussion  
In this study, glass beads and optical fibres were used to measure output ratios and beam 
profiles for field sizes from 10   10 cm
2
 down to 1 1cm
2
. Their performances along with 
two types of well-established dosimeters, having suitable spatial resolution for small field 
dosimetry, were compared with MC calculations.  
For the 4 × 4, 3 × 3 and 2 × 2 cm
2
 field sizes the maximum difference between the measured 
output factors obtained using the glass bead and optical fibres were found to be within 2% 
and 4% respectively from that of MC, while differences of -3% and -12% are present with 
respect to the 1 × 1 cm
2
 field. These % differences from MC are similar to those obtained 
using the ionization chamber for field sizes larger than 1 × 1 cm. The measured output factors 
agreed within 0.8% for the glass beads and 3% for the optical fibres compared against the 
available linear accelerator data for 4 × 4 cm
2 
and 3 × 3 cm
2
 field sizes measured with an RK-
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018 ionisation chamber. Results are also comparable with published data (PTW 2011 and 
Followill et al. 2012) using various solid state and ionization chamber detectors designed for 
small field dosimetry applications after correction for the depth of measurements. The glass 
beads performance matched the closest with the Diod E, microLion and micro-ion chamber 
detectors with a maximum difference of 2% for all field sizes and the optical fibre agreed 
with the PinPoint 0.015 and micro-ion chamber detector with a maximum difference of 3% 
for all field sizes. The largest observed discrepancy is for the optical fibre in a 1 × 1 cm
2
 field, 
which could be due to the volume averaging effect, as the fibres were cut to a length of 5 mm. 
It is indicated that at 1 × 1 cm
2 
and for smaller field sizes there will be a large variation in 
detector response and these results fit within the range of values for various available 
radiation detectors reported in the literature (McNiven et al. 2006; Das et al. 2008; 
Francescon et al. 2011a, 2011b and 2012; PTW 2011). For example a discrepancy of 15% 
between the results from a microLion and Semiflex 0.125 at 1 × 1 cm
2
 field is reported in the 
PTW application guide for small field dosimetry. 
The FWHM values agree with those of MC simulations to within ± 1% for the glass beads 
and to within 1.5% for the optical fibres for all field sizes. The values are similar to those of 
both the ionization chamber 2D-Array and Gafchromic film with even better performance 
than these at 1 × 1 cm
2
. 
All the penumbra values (for both the 80% to 20% range and the 90% to 10% range) agreed 
with those obtained through use of MC simulations to within a maximum difference of 1.4 
mm measured using the glass bead and 1.3 mm measured using the optical fibre. These 
features compare favourably with those of the high-resolution 2D-array of liquid-filled 
ionisation chambers and EBT3 Gafchromic film despite the fact that the 5 mm long optical 
fibre results may be affected by the volume-averaging effect. Reducing the length of optical 
fibre, whilst remaining practically manageable, could improve its performance in small field 
dosimetry. It is noticeable that all differences in penumbra 90-10 values are positive and this 
may suggest that the glass beads over respond. However, all the values are within 
measurement uncertainty and so it is not possible to form a firm conclusion. The density of 
glass beads is less than the density of diodes, 2.09 g/cm³ versus 2.65 g/cm³,and so if there is 
over response it may be expected to be less than that of diodes which are recommended 
dosimeters for small field dosimetry (Griessbach et al. 2006).  
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The glass beads and optical fibres which were used in this work, have a volume of 
approximately 1.5 and 0.078 mm
3
 respectively, therefore, falling into the category of micro 
dosimeters, proving to be effective dosimeters for small field applications in terms of their 
size and minimal volume averaging effects (Lechner et al. 2013). However, both detectors are 
silicon based TLDs and although not soft-tissue equivalent, have shown fairly flat response 
over the MV photon and MeV electron energy range (see chapter 3 and Bradley et al. 2012) 
commonly used in small radiation field applications. Silicon based detectors and mini and 
micro ionisation chambers are generally subject to over-response due to the presence of high-
Z material shielding and steel electrodes, causing beam perturbation (McKerracher and 
Thwaites 2006; Griessbach 2005; Lechner et al. 2013; Underwood et al. 2013). Glass beads 
and optical fibres are used as passive detectors in this work, which mean that they are subject 
to challenges of the time delay before readout, fading effect and the resource intensive pre-
irradiation work, but could also be evaluated positively as chemically inert passive detectors 
that do not require shielding and can avoid the above mentioned problems. In particular, in an 
aqueous environment (e.g. in-vivo dosimetry or measurements in a water tank), they could 
provide superior performance to the other silicon-based solid state counterparts, common 
TLDs and other detectors such as alanine and film which are hygroscopic, and thus require 
shielding.  
 The dose rate independency of the glass beads and optical fibres enables them to be used in 
accurate measurement of the penumbra while it is an identified limitation for other small 
detectors such as diodes and diamond detectors (Michael et al. 2011). In addition, the need 
for only a single irradiation to acquire multiple data points and their reusability may be 
considered as an advantage in the application of glass beads and optical fibre TLDs for 
routine use at low cost for applications such as postal audit dosimetry. 
 
4.5      Conclusions  
The glass beads and optical fibres have been evaluated for their use in small field dosimetry. 
Their performance has been compared to other common detectors, the high-resolution 2D-
array of liquid-filled ionisation chambers and EBT3 Gafchromic film, and also DOSXYZnrc 
MC simulations, measuring output factors and beam profiles for a range of small field sizes 
of a 6 MV photon beam. All detectors were found to agree with Monte Carlo simulations to 
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within 3.5% for all field sizes down to 2 cm
2
 and both dosimetric systems had comparable 
performance against the well-established dosimeters mentioned above. The results therefore 
confirm the potential of the glass bead and Ge-doped optical fibre TLD systems as dosimeters 
for small field, high dose gradient, photon radiation dosimetry when high spatial resolution is 
required, acknowledging that the use of lengths less than 5 mm of optical fibre may be 
beneficial. Efforts to manufacture fibres of greater diameter that may make handling of such 
fibres in shorter length more practical are ongoing (Bradley at al. 2014). Dosimetric 
properties including linear response, dose‐rate and angular independency, high sensitivity, 
large dynamic range and small size of the glass bead and optical fibre TLDs permit them to 
be used as small size dosimeters suitable for accurate determination of output factors, and 
profiles, for field sizes as low as 1   1 cm
2
. In addition the spherical physical shape of the 
glass beads facilitates their use in 2D and 3D arrangements and their reusability, chemically 
inert nature and low cost may be considered advantageous. It is acknowledged that, although 
of low capital cost, the use of such thermoluminescence detectors requires significant labour 
resources. Their application in radiotherapy alongside such established detectors as ionisation 
chamber arrays, EBT3 gafchromic film and small field diodes therefore requires careful 
consideration.  
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5 
 
Use of glass beads in treatment plan 
verification  
 
5.1      Introduction   
Advances in radiotherapy have seen an increase in the use of high precision technologies, 
such as Volumetric Modulated Radiation Therapy (VMAT) and Stereotactic Ablative Body 
Radiotherapy (SABR) (Teoh et al., 2011 and Chang et al., 2007). In high precision 
radiotherapy, individualized treatment verification is necessary to assure the correct dose 
delivery to a patient. This becomes more crucial as delivery techniques move towards the 
reduction of fractionation and increase of the dose. For example in SABR for lung, 
prescription doses of 11-18 Gy in 3-5 fractions are typical (IPEM report 2010). In addition to 
this, such techniques often use small radiation fields, which introduce further challenges in 
dosimetry as mentioned in chapter 4. Resolving these issues requires a detector fulfilling the 
requirements for small field dosimetry and which also provides a large dynamic dose range 
(Aspradakis et al., 2010; Bjarngard et al., 1990; Alfonso et al., 2008; Bassinet et al., 2013 and 
Francescon et al., 2012). 
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The positive characterization of glass bead TLDs discussed in previous chapters and in Jafari 
et al. (2014a, b and c) suggest the potential of glass bead TLDs as dosimeters in complex, 
steep dose gradient radiation fields. In this chapter, the use of glass bead TLDs in pre-
treatment dosimetric verification of complex clinical treatment plans including IMRT and 
SABR VMAT treatment plans has been investigated.  
 
5.2      Material and methods 
5.2.1  Dosimeters 
The dosimeters used in this study were a batch of glass beads (Seed-Petite Beads: Stock#: 
G42010, Mill Hill, Japan) with 1.1 mm thickness, 1.5 mm outer diameter and weight of 3.4 ± 
0.1 mg. The preparation was performed as explained in chapter 3. For each measurement 20 
glass beads were threaded along a cotton yarn, in order to have the same effective length (23 
mm) of measurement as an NE2571 graphite walled cylindrical ionisation chamber (Figure 
1). They were then loaded into a custom built insert.  
  
5.2.2  Phantom and TLD holder insert 
Custom designed plastic (PEEK material) holders matching the NE2571 type cylindrical 
ionisation chamber external shape were made in-house to hold the glass bead TLDs (Figure 
1). A water-equivalent phantom (Solid-Water
®
) slab (30 cm × 30 cm × 2 cm) (Gammex, 
Middleton, WI, USA) with a centrally milled ionisation chamber space was used to ensure 
that the ionisation chamber and TLD holder could be inserted within the solid water phantom 
in the same position. Additional slabs of Solid-Water® were used above and below the 
dosimeter arrangements to provide for measurements with full scatter conditions. 
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5.2.3  TLD reader 
The Harshaw 4500 planchet TLD reader was employed to readout the TLDs using the same 
reading setup as previous chapter.  
 
5.2.4  Measurement procedure 
5.2.4.1  TLD Calibration 
A Varian Clinac 2100C accelerator (Varian Medical Systems, Palo Alto, CA) was used to 
perform all the irradiations. A calibration of the glass bead TLD system was performed to 
determine the absolute dose to water through inter-comparison against the NE2571 ionization 
chamber in solid water (Gammex, UK). To achieve this, the TLD holder with glass beads 
inside was set up such that the EPOM was at 5 cm from the solid water surface. A 10 × 10 
cm
2
 field size was used, at 100 cm focus-surface distance (FSD) to the surface of the solid 
water and a 6 MV photon beam was delivered for 1000 cGy at 400 cGy min−1. The 
ionisation chamber was set up in similar conditions using the same type of solid water. The 
absolute dose to water calibration factor, ND,W TLD, was derived as follows:  
 
𝑁𝐷,𝑊 𝑇𝐿𝐷 =
𝑅𝑖𝑜𝑛 𝑐ℎ𝑎𝑚×𝑁𝐷,𝑊 𝑖𝑜𝑛 𝑐ℎ𝑎𝑚×𝐹𝑇,𝑃×𝐹𝑖𝑜𝑛
𝑅𝑇𝐿𝐷
  (5.1) 
Figure 5.1: (a), the custom made insert to 
hold glass bead TLDs, with the holder 
stem and ionisation chamber insert, (b), 
schematic view of glass beads holder, (c), 
a magnified view of 20 glass bead TLDs. 
arranged on a piece of cotton string. 
23 mm 
23 mm 
(b) 
(b) 
(c) 
23 mm 
(a) 
(b) 
(c) 
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Where Rion cham was the average of at least 4 ionisation chamber readings, ND,W ion cham was the 
absolute dose to water calibration factor for the ionisation chamber (obtained through inter-
comparison against a secondary standard NE2561 ionization chamber following the IPEM 
1990 code of practice (Williams et al., 1990), FT,P was the temperature and pressure correction 
for the Ne2571, and Fion was the ion recombination correction for the Ne2571. RTLD is the 
average glass beads TLD readings for all 20 glass beads. In the case of the conventional 
prostate plan with 15 MV X-rays, an energy correction factor of 1.04 was used to account for 
the slight energy dependence in glass beads TLD response relative to 6 MV photons (see 
chapter 3 and Jafari et al. 2014b).
 
  
The relative individual radiation sensitivity of each glass bead TLD was determined as the 
ratio of the batch average response over the response of each individual dosimeter. All glass 
beads were threaded on a piece of plastic yarn, arranged on a circle and placed together inside 
30 × 30 cm
2 
water equivalent slabs at 5 cm depth, such that all the glass beads were the same 
distance from the central axis to avoid the uncertainty arising from beam flatness as much as 
possible, and exposed to a 10 Gy dose from a 6 MV clinical photon beam in a 10 × 10 cm
2
 
field. These glass beads had a batch homogeneity of 8% (2 SD) so individual correction 
factors were applied.  
It should be noted that dosimetric properties of glass beads may vary from batch to batch and 
careful characterisation for a new batch of glass beads would be required to be used as 
radiation detectors. 
The total standard uncertainty for measuring the relative dose had two constituents: the 
uncertainty of the calibration of the glass beads TLD system arising from the cross calibration 
with the ionisation chamber. Also, the uncertainty in the TLD procedure itself that includes 
the uncertainty of the process of reading the glass bead TLD which is affected by the 
fluctuations of the reader during the day, inconsistency of positioning the glass beads at the 
centre of the planchet and the uncertainties of the individual coefficients and correction 
factors mentioned above. The uncertainty budgets (k=2, i.e. 95% confidence level) for the 
glass bead TLDs are presented in table 5.1. The values presented in table 5.1 are derived from 
the quality assurance (QA) measurements for the linear accelerator and the TLD reader used. 
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Standard deviations of the glass bead TLDs are derived from the response of dosimeters to 
the same dose.  
 
Table 5. 1: The uncertainty budgets for the glass bead TLDs 
Source of uncertainty 
Relative standard uncertainty 
(%), k=2 
Cross calibration of the glass beads TLD against ionisation 
chamber 
0.7 
Determination of individual sensitivity correction factors for 
each glass bead TLD 
1.7 
Dose response linearity of glass beads TLD 0.1 
TLD reading process 2 
Calculated combined standard uncertainty (quadratic 
summation) 
2.7 
 
5.2.4.2  Treatment planning 
A Varian Eclipse V.10  (Varian Medical Systems, Palo Alto, CA) treatment planning system 
and CT data-sets of the Solid Water phantom and glass bead TLDs with 1.25 mm slice 
spacing and thickness were used to calculate the expected dose to the glass bead TLDs. Point 
doses calculated at the centre of each bead were used as values for expected doses. Five 
clinical treatment plans including a larynx (wedged pair), a conventional prostate (4 field 
Conformal plan), an IMRT prostate and two VMAT stereotactic ablative body radiotherapy 
(SABR) lung plans were employed. Their respective beam arrangements and dose 
distributions are shown in figure 5.2. One of the SABR plans used a typical prescription of 11 
Gy and the other a typical high dose prescription of 18 Gy to cover the range of SABR 
radiotherapy dose prescriptions. These plans were copied onto the CT scan of the solid water 
phantom and the dose distribution was recalculated maintaining the original number of 
Monitor Units. The position of the isocentre was adjusted such that a high dose, low gradient 
region was positioned over the bead TLDs and ionisation chamber, as shown in Figure 5.3 for 
the typical prostate IMRT plan. 6 MV clinical photon beams were used for all treatment plans 
except for the conventional prostate plan, where a 15 MV photon beam was used. For 
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comparison, the dose verification was also performed with a NE2571 cylindrical ionization 
chamber. The doses measured with glass beads and ionization chamber were corrected for 
daily output. 
 
 
 
 
(a), Larynx 
(b), Conventional Prostate  
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(c), IMRT Prostate 
(d), SABR Lung (11 Gy/#) 
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Figure 5.3: Position of glass bead TLDs relative to dose distribution after IMRT prostate 
plan export to the phantom (sagittal view). Glass beads were within 100% isodose in a low 
gradient region. 
 
 
Figure 5.2: 5 treatment plans with their respective beam arrangements and dose distributions; 
(a) and (b), static fixed field technique for larynx and prostate, (c), IMRT prostate, and (d) 
and (e), VMAT (RapidArc®) for both SABR. 
Glass beads  
(e), SABR Lung (18 Gy/#) 
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5.2.5  Statistical analysis 
For statistical analysis, the two-sided paired t-test was applied using an Excel programme and 
the P-values were derived from T-scores, to confirm the null hypothesis that there are no 
significant differences between measured doses by the glass bead TLDs and ionisation 
chamber in comparison with expected doses from the TPS. P-values < 0.05 were considered 
to indicate statistical significance. 
 
5.3      Results  
The mean percentage difference between the measured doses with the glass beads and the 
ionisation chamber was found to be ≤ 2.4%.  The difference between the glass bead dose and 
the expected doses calculated by TPS was ≤ 1.8% for all clinical plans. The analysis of the 
results for mean doses is shown in table 5.2.  
 
Table 5.2: comparative mean dose measurements between TPS, ionisation chamber and glass 
bead TLDs. All measured doses were corrected for daily output. 
Clinical site 
Mean dose 
measured 
with TLDs 
(Gy) 
Mean 
expected 
dose 
(Gy) 
Mean % 
difference 
with expected 
dose 
Measured 
dose with 
IC (Gy) 
Mean % 
difference 
with IC 
dose 
Mean % 
difference 
of IC with 
expected 
dose 
Conventional 
Larynx 
1.794 1.789 +0.3 1.815 -1.2 +1.5 
Conventional 
Prostate 
2.241 2.244 -0.1 2.272 -1.4 +1.3 
Prostate IMRT 2.055 2.047 +0.4 2.057 -0.1 +0.5 
SABR PLAN 1 12.097 11.898 +1.7 12.204 -0.9 +2.6 
SABR PLAN 2 18.212 17.891 +1.8 17.795 +2.3 -0.5 
P-value from 
T-test 
  0.87  0.57 0.67 
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Figure 5.4 shows plots of off-axis agreement between glass beads TLD measurements and 
TPS dose profile along the ionisation chamber volume.  
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Figure 5.4: Off-axis agreement between glass beads TLD measurements (×) and TPS dose 
profile (-----) along the ionisation chamber measurement volume. The ionisation chamber 
reading (■) is plotted at its reference point of measurement.  Different radiotherapy 
techniques with typical low, medium and high dose levels were used: (a) a conventional 
Larynx plan using 6 MV photons, (b) a conventional Prostate plan using 15 MV photons, (c) 
An IMRT prostate plan with 6 MV photons and (d and e) SABR techniques using 6 MV 
photons. The X-axis indicates the position of glass beads in regards to farmer chamber 
reference point. The error bars indicate the uncertainty of the whole TLD reading process for 
each glass bead TLD. 
 
5.4      Discussion 
In this work, glass beads were used for patient specific treatment plan verification. The dose 
measurements were compared with results from a cylindrical graphite walled ionization 
11.2
11.4
11.6
11.8
12
12.2
12.4
12.6
12.8
13
-15 -10 -5 0 5 10 15
D
o
se
 (
G
y
) 
Position (mm) 
SABR Lung 
12
14
16
18
20
22
-15 -10 -5 0 5 10 15
D
o
se
 (
G
y
) 
Position (mm) 
SABR Lung 
(e) 
(d) 
 102 
 
chamber. The doses measured by the glass beads agreed to within ≤1.8% from the expected 
doses calculated by the treatment planning system for all the plans, with a P-value of 0.87. 
The dose measurements were also compared with those from an ionization chamber showing 
agreement to within 2.3%, with a P-value of 0.57. It is worth mentioning that the percentage 
differences between ionisation chamber measurement and from the TPS were found to be 
within 2.6% with a P-value of 0.67. Although it is desirable to benchmark glass beads against 
well-established TLD materials, such as 1 mm
3
 LiF: Mg, Ti cubes, nevertheless such TLDs 
have an upper range dose limitation of 10 Gy, and it is not feasible when a high dose range 
(i.e. normally 11 to 27 Gy) QA procedure such as in the SABR technique is required. The 
large dynamic dose range of glass bead is particularly advantageous compared to such well-
established TLD materials. The independence of the glass bead dose response to beam angle 
and dose rate is of importance in rotational delivery techniques used in this study and 
compares favourably with other detectors (such as PTW 2D-ARRAY or MatriXX (IBA 
Dosimetry, Bartlett, TN)) with a dose rate and directional dose response (Wolfsberger et al., 
2010 and Hussein et al., 2013). 
 
The small size of glass beads enabled 20 data points along the effective length of the 
ionisation chamber to be obtained with 1.1 mm resolution. The results demonstrate excellent 
agreement with TPS generated dose profiles within the measurement uncertainty (figure 5.4). 
The advantage of the small size of the glass beads becomes more evident where the delivery 
technique is using more complex beam arrangements, higher dose per fraction and smaller 
field size. In Figure 5.4e a 27% dose differential can be observed across the ionisation 
chamber effective volume (i.e. 4.9 Gy dose in this case). Such a dose differential is masked in 
taking a mean dose across this volume, whereas the glass bead TLDs provide an accurate 
dose profile with resolution of the order of 1mm.   
Although, the performance of glass beads is comparable with the results from the ionization 
chamber, the intense labour resource requirement requires justification for routine use.  
 
5.5      Conclusions 
Glass bead TLDs have been assessed for their use in patient-specific dosimetry verification. 
Their dosimetric properties, including linear dose response, high sensitivity, dose‐rate and 
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angular independency, large dynamic range and small size permit them to be used as small 
size dosimeters suitable for accurate dose determination. Their reusability, chemically inert 
nature and low cost may also be considered advantageous. Nevertheless, the constraint of 
using such thermoluminescent detectors is the significant labour intensive resource 
requirement and hence their application in radiotherapy alongside well established detectors 
requires careful consideration and justification, example situations where their use may be 
justified include in postal dosimetry or aqueous environments of in-vivo dosimetry. That said 
the results confirm the potential of the glass bead TLD system as a dosimeter for treatment 
plan verification when high spatial resolution is required.  
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6 
 
Use of glass beads in an external 
dosimetry audit programme 
 
6.1      Introduction  
Stereotactic ablative body radiotherapy (SABR) is an advanced radiotherapy technique that 
uses a high dose of radiation, stereotactically directed to the tumour. For example, in SABR 
for lung very often a prescription dose of 18 Gy/fraction (in 3 fractions) to the 80% isodose is 
prescribed (IPEM report 2010). In such a situation where a high dose is delivered in a few 
fractions, there are fewer opportunities to correct or adapt the treatment dose. An error in any 
single fraction would have a bigger proportional impact and therefore, the dosimetric 
accuracy is expected to have a greater effect on radiotherapy outcome and therefore, it is 
essential that it be verified by undertaking appropriate quality assurance (QA). Dose errors in 
such cases of the order of 5% can result in 10 to 20% changes in tumour control probability 
and up to 20 to 30% changes in normal tissue complication probabilities (Chetty et al. 2007). 
Radiotherapy audit gives an external independent assessment of the dosimetry and can help 
to identify possible improvements and also find issues which may need addressing 
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immediately (Nisbet et al., 1997; Thwaites et al 1992, 1995 and 1996; Izewska et al., 2003; 
Kron et al., 2013; Clark, et al. 2014; Lye et al. 2014; Ibbott et al., 2015).  
Although, the use of thermoluminescence dosimeters (TLD) as the standard tool for postal 
dose audits is common practice (Aguirre et al. 2002; Ferreira et al. 2000; Ezewska et al. 2000, 
2003; Mizuno et al 2014) TLDs require improvements to face the new challenges introduced 
by advanced radiotherapy techniques and recently several other types of detector have been 
used for audit including seven29 array (PTW-Freiburg GmbH, Germany) and InLight® 
nanoDot OSLD system (Hussein et al., 2013; Clark et al 2014 and Lye et al. 2014). Such 
techniques very often use small radiation fields with high dose gradient (Benedict et al. 2010; 
Jain et al. 2013) which introduce further challenges in dosimetry. The common and well-
established small TLDs, such as 1 mm
3
 LiF: Mg, Ti have been designed for traditional 
radiotherapy practice with an upper range dose limitation of 10 Gy and therefore are not 
suitable for dose evaluation of SABR. Therefore, for postal dosimetry audit of such a 
technique, especially when complex dose distributions and field arrangements are used, an 
ideal detector would be a micro detector with a linear response to a large dynamic dose range 
that also has a very low fading, non-hygroscopic nature and is robust, as irradiation and 
postage return may take some time (Jain et al 2013; Izewska et al. 2002).  
This work has characterised glass beads as a novel high spatial resolution micro TLDs, see 
earlier chapters and Jafari et al. (2014a, b and c). These dosimetric properties suggest their 
potential as dosimeters for multiple direction delivery techniques such as SABR.  
In this chapter, the feasibility of using glass bead TLDs for a postal dosimetry audit is 
assessed in conjunction with the UK SABR Lung Consortium dose audit, run by the 
Consortium QA group. The audit was designed to assess the positional and dosimetric 
accuracy of SABR lung treatment delivery. This was achieved with the use of alanine pellets 
and EBT3 GafChromic film dosimetry, placed in a CIRS lung phantom. 20 volunteer centres 
within the UK collaborated with this feasibility study. 
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6.2      Material and methods  
6.2.1  Glass beads 
The same batch of glass beads that were utilised in chapter 5 were reused for this work. 
 
6.2.2  Glass bead holder insert  
Since initially, the phantom was designed for film and ion chamber dosimetry, custom made 
inserts matching the NE2571 type ionisation chamber external shape were made from tissue 
equivalent material (PEEK) to hold the glass bead TLDs and also to hold alanine. As shown 
in figure 1, for each insert 20 glass beads were threaded along a cotton yarn then loaded into 
the holder, in order to have the same effective length of measurement as the NE2571 
ionisation chamber. All the inserts were coded to keep track of individual glass beads. 3 
inserts and a stem were packed in a black card box and posted to each centre at the same time 
as the CIRS phantom, alanine and film were sent by the SABR consortium audit team.  
 
6.2.3  CIRS Lung phantom 
Five CIRS IMRT Thorax Phantoms (The CIRS Model 002LFC) (figure 6.1) were used for 
the Lung SABR dose audit. It is an anthropomorphic phantom with lungs and spinal cord in 
thorax shaped solid water, which can be used for commissioning as well as comparison of 
TPS calculated plans and measurements.  
A CT scan of a CIRS lung phantom was performed by the SABR consortium audit team at 
the Royal Surrey County Hospital with 1.25 mm slice spacing and thickness. Volumes 
relating to the ITV and alanine pellets were predelineated. This CT scan set was sent to 
centres and it was loaded into their treatment planning system.  
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6.2.4  Audit Documents  
In addition to dosimeters, the following documents, dosimetry protocols and instruction 
sheets were prepared and sent to each centre: 
 A dosimetry audit protocol, which was prepared by the SABR consortium audit team, 
provided explanation of the phantom description, handling, CT-scanning and 
planning, EBT3 GafChromic film dosimetry and returning film for processing, 
alanine dosimetry and return to the National Physical Laboratory for readout. 
 GafChromic film irradiation record form 
 Alanine irradiation record form 
 Glass beads introductory document (appendix 1) 
 Glass beads dosimetry instruction and irradiations record form (appendix 2) 
  
 
6.2.5  Measurement procedure 
6.2.5.1  Absolute dose measurements using alanine dosimeters 
For absolute dosimetry, the glass beads were cross calibrated against alanine dosimeters in 
reference conditions. To perform absolute dosimetry with sufficient accuracy using alanine 
Glass bead insert 
(a) 
Figure 6.1: (a), The CIRS Lung phantom with 
glass beads insert showed by a red circle. (b), 
schematic view of glass beads insert, (c), 20 glass 
bead TLDs arranged on a piece of cotton yarn.    
(b) 
(c) 
(d) 
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pellets, a dose of greater than 10 Gy is ideally required (Sharpe et al. 2006). At 10 Gy, the 
uncertainty associated with the calibration of alanine dosimeters is 0.85% (k = 1) and the 
pellet to pellet reproducibility is 0.5% (k = 1) (Sharpe et al. 2006; Budgell et al. 2011). 
Centres were therefore requested to also irradiate a set of glass beads at a dose of 10 Gy at the 
same beam energy and under the same experimental conditions. For this measurement the 
local ion chamber was set up in a solid water slab Phantom. The phantom was centred at the 
NE2571 chamber reference point. The calculated MUs, for a 10 cm × 10 cm field size and 6 
MV energy at reference condition of each centres was first delivered to the NE2571 chamber 
in order to check the dose was as expected and then to the alanine in one of the inserts and 
subsequently to a set of glass beads.  
The irradiated alanine pellets, were analysed by the National Physical Laboratory using an 
EPR spectrometer and the results were received in terms of dose (Gy).    
 
6.2.5.2  SABR Plan  
Each centre created a S plan on the scan of the CIRS lung phantom using their current 
planning protocol and technique. The plan covered the PTV which contained 9 alanine pellets 
and thus, the glass beads that in turn sit along the central axis of the alanine pellets (figure 
6.2). 
 The dose of SABR plan was first measured with the local ionisation chamber by placing the 
chamber in the posterior part of the left lung and then to a set of glass beads. The phantom 
was then dismantled, the gafchromic film and alanine pellets were then put in position and 
the measurement was performed for the main audit.  
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Figure 6.2:  An example of the dose distribution of treatment plan covered the PTV which 
contained 9 alanine pellets/ glass beads that sit along the central axis of the alanine pellets (an 
overlapped picture of 20 glass beads treaded on a black cotton yarn and 9 alanine pellets out 
lines is shown to clarify the position of glass beads relative to alanine pellets). The alanine 
pellets sits on the effective volume of a farmer chamber in turn.  
 
6.2.5.3  Uncertainty analysis 
Three major sources of uncertainty in the dose determination were: 
 uncertainties associated with the calibration of the glass bead TLDs consistency 
against alanine dosimeters  
 uncertainties in the determination of individual sensitivity correction factors for glass 
bead TLDs 
 the uncertainty associated with the glass bead TLD themselves  
Dose response linearity, fading, and energy corrections factors are commonly applied for 
TLD analysis (Kirby et al. 1992). The fading and energy correction factors were not relevant 
for this work as the absolute dose calibrations for the glass beads were performed on the day 
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of reading and all treatment plans utilised 6 MV energy. Small variations of quality index for 
this nominal energy among facilities was considered to have a minimal effect. The 
uncertainty budgets for the glass bead TLDs are given in a previous chapter (table 5.1). 
Standard deviations of the glass bead TLDs are derived from the response of dosimeters to 
the same dose. The reproducibility of each individual TLD was found to depend on the 
stability of the TLD reader output as well as consistency in the positioning of beads on the 
planchet and annealing procedure (chapter 3 and Izewska et al. 2002; Jafari et al. 2014). 
No phantom dependent correction has been applied. The geometry and density variations 
between five identical phantoms were checked and considered to be negligible.  
The analysis of % differences of glass beads results with alanine, ionisation chamber and TPS 
may be affected by small errors in the positioning of the TLD holders. For the majority of 
plans the dose distribution within the treatment volume is uniform and the movement of the 
TLD by up to 5 mm from the position stated would change the dose by up to 2.2% which is 
the highest standard deviation of dose distribution across a 5 mm diameter alanine pellet.  
 
6.3      Results 
22 SABR treatment plans were measured. Delivery techniques varied amongst the centres; 6 
centres used the conformal technique, 11 centres used VMAT and 3 centres used Cyberknife, 
all using 6 MV photon beams. The glass bead results were analysed using the alanine 
reference measurement for dose calibration. The % differences of SABR plan doses 
measured with glass beads from alanine, local farmer chamber, film and TPS predicted doses 
are shown in figure 6.3. 
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Figure 6.3: The histogram of comparison between glass bead results and measurements with 
alanine, ionisation chamber, film and TPS expected doses. 
 
6.4      Discussion 
In this work, glass beads were used for a feasibility study for dosimetry audit performing 
point dose measurements. Their performance was compared with alanine, ionisation chamber 
and film dosimeters. The mean % difference between the measured doses by the glass beads 
and the calculated doses by the TPS was found to be 0.7% (sd=2.0) and differed by 0.6% 
(±1.5), 1.3 % (±1.4) and 0.7 % (±2.3) from alanine, local ion chamber and film measurements 
respectively. Although these levels of discrepancy are within the measurement uncertainty, 
all the cases with greater than 2% discrepancy went through a detailed check. It was found 
that dose distributions in the treatment plan of these cases were less homogenous, such that 
they had up to a 2.2% standard deviation of dose within a 5 mm area. Therefore, it is 
suggested that setup variation between glass beads and alanine measurements (This could 
have happened due to placement and removal of the film) could be the main reason for these 
greater differences. 
The positive value of mean % differences may suggest that, like other silicon based detectors 
(McKerracher et al. 2006; Lechner et al. 2013) the glass beads slightly over respond. This 
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was also noticed in previous work, see section 4.4 and Jafari et al. (2014c).  However, all the 
values are within measurement uncertainty and so it is not possible to form a firm conclusion. 
The density of glass beads is less than that of diodes (chapter 3 and Jafari et al. 2014b), which 
are routine dosimeters for clinical dosimetry (Griessbach et al. 2006), hence if there is over 
response it is expected to be less than that of the diodes which is reported to be about 7% 
(Huang et al. 2003).  
The range of doses used by the centres in this audit varied from approximately 15 to 27 Gy. 
The large dynamic dose range of glass bead is particularly advantageous in these 
circumstances, compared to other well-established TLD materials, such as 1 mm
3
 LiF: Mg, Ti 
cubes, which are designed for conventional radiotherapy dose range with an upper range dose 
limitation of 10 Gy. The independence of the glass bead dose response to beam angle and 
dose rate is of importance in rotational delivery techniques used in this study and compares 
favourably with other detectors such as diamond detectors and ionization chamber 2D-arrays 
with a dose rate and directional dose response (Ade et al. 2014; Wolfsberger et al. 2010 and 
Hussein et al. 2013). 
Along with these encouraging results, the inert nature and low fading of these glass bead 
TLDs suggest that they can be a suitable tool for postal dose audits without concerns 
regarding the temperature, humidity and handling conditions that the audit parcel may 
experience. Particularly, when a large number of TL dosimeters for such application is 
required a further advantage is the low cost and ease of availability. 
 
6.5      Conclusions  
The glass beads have been evaluated for their use in postal dosimetry audit by undertaking a 
feasibility study alongside an audit conducted at 20 radiotherapy centres within the UK 
assessing positional and dosimetric accuracy of SABR lung treatment delivery. Their 
performance has been compared to alanine, ionisation chamber, film dosimeters and 
predicted doses by the treatment plans and agreed well with the above-mentioned dosimetry 
systems. Dosimetric properties including linear response over a wide range of doses, low 
fading, dose rate and angular independency, high sensitivity in addition to their reusability, 
chemically inert nature and low cost is advantageous for their application in postal dosimetry 
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services where the low fading, non-hygroscopic nature and robustness is important  and 
where irradiation and postage return may take some time. The results therefore confirm the 
potential of the glass bead TLD systems as dosimeters for postal audit. 
The results are encouraging and their application in postal dosimetry services is an example 
where the low fading, non-hygroscopic nature and robustness is important where irradiation 
and postage return may take some time. In particular, where more complex dose distributions 
and field arrangements may be required to be measured (Jain et al 2013; Izewska et al. 2002). 
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7 
 
Use of glass beads in hadron-therapy; 
a preliminary investigation 
 
7.1      Introduction  
The use of charged-particle beams in radiotherapy is becoming a topic of increasing interest, 
with the rise in the number of clinical proton therapy facilities worldwide (Allen et al. 2012) 
and launch of heavy ion medical centres such as Gunma University Heavy Ion Medical 
Centre (GHMC) in Japan (Ohno et al. 2011).  
The advantages of charged particle therapy are to be found in; a low entrance dose and thus 
low doses to the normal tissues in the radiation beam before the tumour, and a high dose near 
the end of range (Bragg peak) with the precise lateral and distal cut off, a property that can be 
used to aid delivery of a relatively high dose to the tumour. Beyond the Bragg peak, the 
energy deposited by the protons falls to close to zero therefore, if positioned accurately 
almost no dose is received by normal tissues distal to the tumour. 
Moreover, charged particles have various radio-biological advantages in terms of high LET, 
including a decreased oxygen enhancement ratio, a reduced capacity for sub-lethal and 
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potentially lethal damage repairs, and reduced cell cycle-dependent radio-sensitivity 
compared with those observed with protons or X-ray beams (Ando et al. 2009). 
TL light transparency is one of the important characteristics of glass bead TL dosimeters in 
their potential application for charged-particle beams that have high LET and therefore can 
deposit dose non-uniformly across a detector. Readout of TL detectors can be influenced if 
any opacity is present causing self-attenuation of TL light with potentially different readout 
values from different sides of the detector seen in cases where deposition is not central 
(Besserer et al. 2001; Bilski and Budzanowski 2001). In a previous study (see section 3.6.1.2 
and Jafari et al 2014a), the relationship between the mass of the glass bead and TL light was 
found to be linear, confirming a well-behaved transparency of glass beads to TL light and 
pointing to the potential for largely avoiding self-attenuation issues.  
Furthermore, in charged-particle beams there is a high multiplicity of tracks, with the 
secondary charged particles, especially the low-energy protons/charged-particles and recoil 
heavy nuclei, being able to cause significant radiation damage to the lattice of crystalline 
silicon-based detectors (Loncoly et al. 1996; Rikner 1983; Smirnov et al. 2013). Conversely, 
glass beads are made of amorphous material that is more resistant to radiation damage. It is 
known that after thermal treatment a silicon based material can recover from radiation 
damage (Tench and Duck 1973; Sowa et al. 2012; Zhang et al. 2012 and Platkevic et al. 
2013). With glass beads an annealing procedure is part of the TLD preparation, and hence 
overall it is expected to suffer limited radiation damage, particularly when compared with 
other dosimeters as in those with active electronic components that cannot receive thermal 
treatment.  
This study assessed the dosimetric characteristics of the glass beads as TL dosimeters with 
respect to linearity, reproducibility, and dose rate, for the clinical proton beam produced at 
the 62 MeV Douglas Cyclotron unit located at Clatterbridge Hospital and for the 290 MeV 
carbon ion beam produced by a clinical synchrotron at the Gunma University Heavy Ion 
Medical Centre, Japan. Further to characterisation studies, application of glass beads in Bragg 
Peak and beam profile measurements of proton and carbon ion beam was investigated. 
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7.2        Characterization measurements using charged 
particle beams of proton and carbon ion 
7.2.1  Material and methods 
7.2.1.1  Glass beads 
The same batch of glass beads (Petite: Stock#: G42010, Mill Hill, Japan) that were used in 
chapter 4 was utilized for this part of study. The dosimeters were calibrated in terms of 
sensitivity by irradiating the glass beads in a water equivalent phantom using a nominal 6 
MV clinical photon beam at 5 cm depth and a field size of 10 × 10 cm
2
. Detailed calibration 
process is given in chapter 5 (section 5.2.4.1). The Harshaw 4500 planchet TLD reader was 
employed to readout the glass beads.  
 
7.2.1.2  Phantom  
Two novel thin window water tank phantoms, with inner dimensions of 33 cm long (in 
direction of beam travel), 28 cm wide and 29 cm deep, and 12 cm long (in direction of beam 
travel), 10 cm wide and 15 cm were designed by NPL and made up of Perspex with an 
entrance window made up of Mica (50 mm diameter and 0.1 mm thickness). For this work 
perspex jigs were designed and manufactured to position the glass beads in water (figures 7.1 
(a) and (b).  
 
7.2.1.3  Irradiation procedures 
7.2.1.3.1  Irradiations with a proton beam 
All measurements were performed using a 62 MeV proton beam located at the Douglas 
Cyclotron centre at Clatterbridge Hospital by NPL staff. The beam has a diameter of 30 mm 
and a range in water of 32 mm. Glass beads were irradiated within a water tank.  
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7.2.1.3.1.1   Dose response and reproducibility 
To assess the dose response performance of the glass beads, doses ranging from 1 to 100 Gy 
were delivered at a constant dose rate of 20 Gy min
-1
. The reproducibility of the glass bead 
response was tested by performing three consecutive irradiations of 12 Gy to three sets of 
glass beads from the same batch, using a constant dose rate of 20 Gy min
-1
. 
 
Figure 7.1: (a), the water filled phantom with thin window (0.1 mm thickness) set up to 
position the glass beads. The glass bead TLDs can be seen in the phantom. (b), the detail of 
the bead holder jig. The beads were threaded on a string and stretched between the two posts. 
Coloured beads were added to identify the batch. 
 
7.2.1.3.1.2   Dose rate dependency 
The dose rate dependence was tested by delivering a constant dose of 12 Gy using different 
dose rates, from 5 to 100 Gy min
-1
.  
Glass bead TLDs 
Mica Window 
(b) (a) 
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7.2.1.3.2  Irradiations with carbon ion beam 
All measurements were performed using a 290 MeV carbon ion beam with a diameter of 11 
cm and a range in water of 14 cm produced by a clinical synchrotron at the Gunma 
University Heavy Ion Medical Centre, Japan. Glass beads were irradiated within a 35 x 30 x 
30 cm water tank. 
 
7.2.1.3.2.1   Dose response and reproducibility 
To assess the dose response performance of the glass beads, doses ranging from 1000 to 
180000 pulses were delivered at a constant dose rate. The reproducibility of glass bead 
response was tested by performing three consecutive irradiations of 15000 pulses and two 
consecutive irradiations of 30000 pulses to five sets of glass beads from the same batch, using 
a constant dose rate. 
 
7.3         Bragg Peak and beam profile measurement using 
glass beads in proton and carbon beams 
7.3.1  Introduction 
The dosimetric characteristics of various types of dosimeter for charged particle beams have 
been widely reported, most have limitations related to volume averaging and dose 
underestimation in a pristine Bragg Peak (Azangwe et al 2014). A common issue is decreased 
response with increasing ionization density of the radiation field, this may lead to dose 
underestimation in the Bragg peak of heavy charged-particles (Rah et al. 2012) which is also 
known as the “quenching effect” and reported most for chemical dosimeters such as film, 
polyacrylamide gels (PAG), Fricke gels, PRESAGE®, and alanine (Doran et al. 2015; 
Baldock et al 2010 and Gustavsson et al. 2004). This phenomenon is not yet fully understood; 
the high-dose saturation, ion-recombination, and track structure theory are possible 
explanations by Gustavsson et al. (2004); Jirasek et al (2002); Katz (1978); Zhao (2012) and 
Gorjiara T et al (2012). 
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Although, TLDs also have shown to be LET dependent, their use in modulated proton beams 
tends to smooth out the effect of LET dependence (Sabini et al. 2002 and Zullo et al. 2010) 
and makes them interesting dosimeters for proton dosimetry. 
Further to this, Bragg peak dosimetry and beam profile measurement demands high 
resolution capability due to the steep dose gradients present in the peak region and beyond. 
Moreover, there is the need for appropriate detectors for small fields such as one used for 
ocular treatment. In addition to the attractive physical properties of glass beads as described 
in detail in earlier chapters, the linear dose response of glass bead TLDs to the charged 
particles of proton and carbon ion beams along the glass bead size may be able to address 
both requirements. 
This section presents a preliminary investigation of measurement of proton beams profiles 
and Bragg peak measurements of proton and carbon ion beam using glass bead TLDs and 
optical fibres. This is ongoing work with the collaboration of NPL and is dependent on beam 
access to appropriate proton and carbon ion facilities.  
 
7.3.2  Material and methods 
7.3.2.1  Glass bead and optical fibres 
The same batch of glass beads and optical fibres that were used in chapter 4 were utilized for 
this part of the investigation. The same preparation methodology was applied for both 
detectors except that optical fibres were cut in 3 mm length.  
 
7.3.2.2  Measurement procedure 
7.3.2.2.1  Beam profile 
The beam profile measurement was performed at the Clatterbridge Cancer Centre 62 MeV 
proton beam facility with a 30 mm diameter collimator. The phantom, described in section 
7.2.1.2, was used with a Perspex jig that was designed with two legs such that it could hold 
the glass beads inside the water tank by gripping both ends of the plastic yarn that the glass 
beads were threaded on (figure 7.2), positioned at 27mm depth of water.  
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Figure 7.2: Perspex jig with two legs holding the glass beads.   
 
7.3.2.2.2  Bragg Peaks  
The percentage depth dose distributions were 
measured in water phantoms using the two 
Perspex jigs specially designed for this study 
(figure 7.2 and 7.3). For the proton beam, the jig 
was made to hold two lines of 40 glass beads that 
were threaded on plastic yarns such that they 
were held in a V shape, to minimise shielding 
from neighbouring detectors. This arrangement 
of detectors also allowed two simultaneous 
measurements of the Bragg peak in a single 
irradiation. The carbon ion beam had a longer 
range and a different setup was used to avoid 
Figure 7.3: Schematic view of Perspex 
jig specially designed to hold the glass 
beads for percentage depth dose 
measurement of proton beam. 
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detector line sag. A sheet of Perspex was designed with three lines of hemispherical holes to 
hold three lines of glass beads that were threaded on plastic yarns such that they sat with 2 
mm spacing from centre to centre. Optical fibres were arranged on sticky note paper with 1 
mm spacing distance and covered with a very thin layer of plastic film and then taped on to 
the jig (figure 7.4 (a) and (b)).   
To minimise shielding from neighbouring detectors, the Perspex sheet was tilted by a few 
degrees and a geometrical correction for this tilt was applied to the results. This arrangement 
of detectors thus allowed four measurements of the Bragg peak using one irradiation.  
For comparison, the depth-dose distribution was also measured with a Markus type plane-
parallel ionization chamber (PPIC) (PTW, TB23343). This is the standard detector employed 
by the Clatterbridge Proton facility for such measurements.  
 
(a) 
(Glass beads) 
(Highlighted position of optical fibres) 
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Figure 7.4: (a), experimental setup for the Bragg peak measurement of the carbon ion beam 
and a magnified view of the position of the glass bead TLDs and optical fibres. The optical 
fibres are not visible in the photo but the black lines highlight their position. (b), the 
schematic view of the Perspex jig to hold the glass bead TLDs and optical fibres for 
percentage depth dose measurement of carbon ion beam. 
 
For high gradient regions, such as in the Bragg peak, the diameter of the detector, in 
comparison to the width of the peak or steepness of the gradient, plays an important role. A 
non-uniform dose distribution over the detection volume leads to a volume averaging effect 
because the detector readings are proportional to the average dose over the sensitive volume 
of the detector. The detector readings are therefore lower than they should be at the peak and 
higher than they should be at the beam fall off region when the detector extends laterally into 
the non-uniform region of the dose and the readings thus have to be corrected for this effect. 
The depth dose distribution obtained with the PPIC was used for the calculation of correction 
factors for the volume averaging effect in the proton beam measurements, as plotted in figure 
7.5(a). For the carbon ion beam measurements, the data analysis is ongoing and is planned to 
be completed in collaboration with NPL as part of future work. This will require the use and 
analysis of NPL collected data for the calculation of correction factors for the glass bead 
TLDs.    
 
(b) 
(Glass beads) 
(Optical fibres) 
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2 mm 
The volume averaging correction factor, c
vol_av
, was calculated as the ratio of the PPIC 
reading at a particular point to the average readings of PPIC for all data points covered by the 
volume of the glass bead in each setup. Therefore, considering the step size of PPIC data 
points (0.177 mm interval) in the direction of the Bragg Peak, an average of 11 measurement 
points were employed to correct for the 2 mm length that a glass bead occupied (figure 
7.5(b)). 
 
Figure 7.5: (a) Volume averaging correction factors as a function of depth described in 
section 3.1 for an unmodulated 62 MeV beam. (b) A schematic view of glass bead’s position 
(cylindrical shape) relative to the PPIC data points (vertical lines). 
 
7.4      Results and discussion 
7.4.1  Dose response and reproducibility 
With the proton and carbon beam, the glass bead TLDs were also found to have an excellent 
linear relationship over the respective dose ranges of 0.5–100 Gy and approximately 0.01-25 
Gy, with a correlation coefficient of R
2
 = 0.999. Figure 7.6 shows a plot of the response of 
the dosimeter versus the applied absorbed dose from proton beam as determined by an 
ionization chamber. Each data point represents an average value of eighteen readouts. 
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Figure 7.6: Dose response of glass bead over the dose range of 0.5 – 100 Gy, irradiated using 
62 MeV protons. The error bars represent the uncertainty on the slope. 
Figure 7.7 illustrates the dose response of glass beads over the approximate dose range of 1 
cGy to 25 Gy from 290 MeV carbon ion beam. The error bars represent the uncertainty on the 
TLD readout process. 
 
Figure 7.7: Dose response of glass beads over the dose range of 1000 – 1180000 pulses 
(approximately equivalent to 1 cGy to 25 Gy), irradiated using 290 MeV carbon ion beam. 
The error bars represent the uncertainty on the TLD readout process. 
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7.4.2  Dose rate dependency 
The standard deviation for the dose rate response using a proton beam was also found to be 
within ≤ 1% over a wide range of dose-rates, from 5 Gy min-1 to 100 Gy min-1 (figure 7.8). 
Each data point indicates the mean value and the error bars are showing one standard 
deviation from readouts of four glass beads. 
 
 
Figure 7.8: TL response of glass beads irradiated with the same dose (i.e. 12 Gy typical 
patient fraction at CCC) delivered at different dose rates of 5-100 Gy/min, using 62 MeV 
protons. Within the evaluated uncertainties no dependency on dose-rate is apparent.    
 
7.4.3  Beam profile 
Figure 7.9 shows beam profiles measured at a depth of 27 mm in water with the glass bead 
TLDs. This depth was chosen for practical reasons due to the configuration of the jig. Data is 
normalised to the dose at the central axis.  
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Figure 7.9: Beam profiles obtained with the glass bead TLDs irradiated with 12 Gy, 62 MeV 
proton beam.  
 
An asymmetry of the beam profile was noticed with the results from glass bead TLDs and 
reported to the centre. Further investigation was made at the centre and it was noticed that 
although quality control was being performed at the beginning of the measurements, during 
long time intervals over which the measurements were performed, the beam was drifting. As 
the result, the unit was adjusted and further quality control plans were considered at the 
beginning, middle and end of measurements. The beam profile data was obtained from the 
measurements that were designed for the linearity study. A beam profile measurement at 
beam entrance window was obtained using gafchromic film, but since the shape of the proton 
beam profile changes with the depth (Grevillot et al 2012),  there was therefore no 
comparable data from other detectors and further measurements are required for a complete 
study of beam profile. It is worth mentioning that the depth of measurement was merely due 
to the practical setup and the size of the Perspex jig’s top. The Perspex jig’s top is now 
modified to enable for further beam profile measurements at different depths and experiments 
are planned as part of future work.  
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7.4.4  Percentage depth dose (Bragg Peak) 
Figure 7.10 shows a comparison of the depth–dose distribution for a 62 MeV unmodulated 
proton beam obtained with the Markus type ionization chamber and the glass beads, showing 
both the raw data and that corrected for volume averaging. 
 
Figure 7.10: Comparison of the Bragg peak depth–dose curve obtained with the glass bead 
dosimeter and Markus ionization chamber for unmodulated proton beams. All data are 
normalized at the beam entrance.  
 
The ratio of the dose measured in the maximum of the Bragg peak to the dose in the entrance 
region of the Bragg curve was 4.79 with the ionization chamber and 4.63 with the glass 
beads. The Bragg peak depths determined from the ionization chamber and the glass 
dosimeter were 31.88 mm and 32.23 mm, respectively. The FWHM obtained with the glass 
bead dosimeters was 3.8 mm, being slightly wider than the 3.6 mm obtained with the PPIC, 
however agreeing to within 0.2 mm.  
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Figure 7.11 shows the raw data of the depth–dose distribution for a 290 MeV unmodulated 
carbon ion beam obtained with the Markus type ionization chamber, the glass bead TLDs and 
optical fibre. 
 
Figure 7.11: Initial data of Bragg peak depth–dose curve obtained with the glass bead TLDs, 
Markus ionization chamber (PPIC) and optical fibres for 290 MeV unmodulated carbon ion 
beams. All data are normalized at the beam entrance. 
 
It is evident from figure 7.11 that depth dose measurement with the glass bead TLDs and 
optical fibres show good correlation with parallel plate chamber apart from an under-response 
in the Bragg peak. Volume averaging, step position and possible quenching effects may have 
caused the under-response in the Bragg peak region. Detailed data points from parallel plate 
chamber measurements is awaiting for further analysis of the results. Refinement of 
experimental design may also address some of these issues which is part of the future work. 
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7.5      Conclusion  
The dosimetric characteristics investigated, have demonstrated that there is potential for the 
use of glass beads as TLDs for verification measurements in charged-particle therapy. 
Additional work planned to complete this part of the study are described in detail in chapter 
8. 
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8 
 
Conclusions and suggestions for future 
work 
 
8.1      Conclusions  
Based on the GLOBOCAN 2008 estimates, about 12.7 million cancer cases and 7.6 million 
cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 64% of 
the deaths occurred in the economically developing world (Jemal et al. 2011). In other words, 
it leads to ~20-30 percent cumulative mortality globally. It is recommended that 
approximately 50% of newly diagnosed cancer cases would benefit from radiotherapy in 
current medical practice (Delaney et al. 2005). The essential goal of radiation therapy is to 
obtain the greatest possible tumour control, with the least healthy tissue complications. As 
much as recent advances in radiation therapy techniques improve the treatment delivery to 
achieve this goal, these techniques also come with greater demands on the performance and 
accuracy of radiation dosimetry systems. 
The evolution of radiotherapy and development of new equipment, accessories and new 
techniques such as IMRT and SABR, have the potential to significantly enhance the outcome 
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of cancer therapy. This, however, has increased the cancer patient care level gap between 
advanced and developing countries. Establishment of these high-tech radiotherapy techniques 
are very difficult in most of the developing countries due to the shortage of expertise, budget 
and lack of maintenance, whereas these populations have more than half of the cancer 
incidence rate in the world (Jemal et al. 2011). The development of a high performance 
simple dosimeter with low maintenance, whilst being affordable would be appreciated. 
Therefore, the main objective of this research was to develop an inexpensive, readily 
available and reusable radiation dosimeter that would comply with the requirements of 
modern radiotherapy technology, and potentially bring down the cost of cancer care in 
developing societies, regardless of the country‘s economic situation. 
In this work the dosimetric properties of low cost commercial glass beads have been 
investigated, focussing on those characteristics that are particularly relevant to medical 
dosimetry of radiation therapy dose levels (1–100 Gy). In particular, for their use as a novel 
dosimetry system for QA procedures in radiotherapy.  
Glass beads are available in different colours and a range of sizes. Although, colourful beads 
are preferred for ease of visibility and handling, their radiation response varied enormously 
depending on the readout systems. The size of bead was selected as a compromise between 
spatial resolution, handling ability and the signal to noise ratio of the readout. An EPR and a 
TL read out system were utilised and the optimum readout system for the glass beads was 
selected considering the minimum detection level, accessibility and the ease of use. 
Accordingly the clear transparent glass beads of 1mm and the TL readout system were 
chosen for detailed investigation of dosimetric properties with respect to dose response, 
reproducibility, linearity, dose rate, angular and energy dependence. 
These dosimetric characteristics of the glass bead were evaluated utilizing a range of 
modalities and energies of clinical beams; photons, electrons, and proton and carbon ions. 
The results were promising, offering in many cases a better performance in comparison with 
commonly available TL dosimeters; for example a better batch homogeneity, a linear 
response over a large dynamic range from mGy to more than 100 Gy that covers the whole 
radiotherapy dose range, a response independent from dose rate and angle of incident beam, 
lower fading and an almost flat energy response over the megavoltage energy beams 
investigated. These results encouraged investigating their different clinical dosimetric 
applications with TL system.  
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Having the abovementioned positive characteristic results for the glass beads, the next step 
was to benchmark the performance of the dosimeter with established, more common 
detectors for small field dosimetry applications. The beads performance was compared to the 
high-resolution 2D-array of liquid-filled ICs, optical fibre and EBT3 Gafchromic film, and 
also DOSXYZnrc MC Simulations, in measuring output factors and beam profiles for a range 
of small field sizes of a 6 MV photon beam. The results confirmed the potential of the glass 
bead TLD system as dosimeters for small field, high dose gradient, photon radiation 
dosimetry when high spatial resolution is required.  
Furthermore, the utilization of glass bead TLDs was investigated for patient specific 
treatment plan dosimetry verification by performing point dosimetry. Different radiotherapy 
techniques with typical low, medium and high dose levels were used. The overall 
performance agreed to within 1.8% from the expected doses calculated by the treatment 
planning system for all the plans, and within 2.4% with those from an ionization chamber. 
The dosimetric characteristics and small size of dosimeters made them suitable for accurate 
dose determination from simple to complex beam arrangements and dose distributions 
covering different delivery techniques of static and rotational radiotherapy.  
The potential of the glass bead TLD system as a dosimeter for treatment plan verification, 
particularly when high spatial resolution with a high dose complex treatment delivery is 
required, as well as their low cost, small size, robustness, inert nature and minimal fading 
characteristics encouraged a feasibility study using glass bead TLDs for a postal dosimetry 
audit programme of lung SABR techniques. Glass bead TLDs are potentially an excellent 
candidate for such applications when it is difficult to control the environmental factors such 
as humidity and temperature and possible postage delays of dosimeters may take some time. 
A feasibility study was conducted alongside a dosimetry audit conducted within 20 UK 
radiotherapy centres. Their performance was evaluated against alanine dosimeters as a well-
established reference dosimetry system, film, ionisation chamber and TPS predicted dose. 
The results agreed with a mean percentage differences of 0.6%, 0.7%, 1.3% and 0.7% 
respectively, confirming the potential of glass beads to be used in postal audits. In this 
application, the large dose range of glass beads was advantageous in particular when 
compared with commonly available TL materials. Most of the small size TL materials have 
been made in regard to the dose level of conventional radiotherapy (2-3 Gy) and have an 
upper dose limit of 10 Gy, whereas there is an increasing practice of hypo-fractionation for a 
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range of applications (AAPM TG 101; Jain et al. 2013). For example, the average dose level 
for the UK SABR audit was 20 Gy. Furthermore, a large number of glass bead TLDs was 
used in this work which cost £2.49 which, for example, is much cheaper than the price of a 
single TLD 100.  
As glass beads TLDs were shown to respond linearly to dose in proton beams, a further step 
was to study their potential for the measurement of depth dose distribution (Bragg Peak) and 
beam profile using a 62 MeV proton beam at the Clatterbridge Cancer Centre facility. The 
results of the beam profile measurement showed a significant beam steering offset and this 
was brought to the attention of the proton therapy centre. It was found that although the beam 
steering was checked before the start of measurements, it was not checked during and at the 
end of measurements as it was not expected to be significant. Therefore following these 
results, the unit underwent maintenance to solve the beam drifting issue. 
The Bragg peak measured data, after correction for volume averaging, was found to compare 
favourably with those from the parallel plate ionization chamber, which is currently the 
standard dosimeter for proton beam dosimetry at the facility. The TL light transparency of the 
glass beads was of particular interest in this work as the opacity of common TLDs is a 
constraint for high LET beams as the energy is deposited heterogeneously. The results from 
preliminary investigation with the glass bead TLD did not show significant quenching effect, 
however, since the measurements were done only once, this positive result needs 
confirmation by performing a further detailed investigation with modulated (spread out Bragg 
peak) and unmodulated proton beams. Due to limited availability of the beam it was not 
possible to repeat the experiment within the timescale of this thesis.  
 
8.2      Future work 
A preliminary study of using glass beads in proton and carbon ion dosimetry was performed 
with the NPL in collaboration with the Clatterbridge Cancer Centre and the Carbon ion 
facility at the Gunma University Heavy Ion Medical Centre (Ohno et al. 2011). The 
preliminary results of glass beads have shown a linear dose response and beam range 
determination comparable to those with the Markus type ionization chambers. Further data 
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analysis and refinement of experiments are required for a better understanding of the 
dosimetric features of the beads in charged-particle beams.  
Even though the results of these investigations are very promising for megavoltage beam 
energies, the main drawback of glass beads is that they are not soft tissue equivalent and this 
needs very careful characterisation if they are intended to be used, particularly at the kV 
range of beam energies. There are reports on the potentials of plastics for passive dosimetry 
with EPR (Sholom et al. 2010; Trompier et al 2010) and recently, high temperature resistant 
transparent polymers, such as Akron Polymer Systems (www.akronpolysys.com) have 
become commercially available, therefore, as plastics are almost tissue equivalent, it will be 
interesting to see if plastic beads can be used for dosimetry purposes using either of the 
earlier mentioned readout systems.  
In addition to the TL studies reported in this work, Optically Stimulated Luminescence (OSL) 
and Radiophotoluminescence (RPL) dosimetry systems may be further options to readout the 
glass beads. In particular, the RPL properties of glass beads are of interest due to the 
possibility of a non-destructive repetitive readout using this technique. The RPL system has 
recently become a standard dosimetry system particularly in Japan (Mizuno et al., 2008) and 
is now the chosen system for their dosimetry audits with some organisations.  
Although of low capital cost, the use of a large number of glass beads as high resolution 
thermoluminescence detectors for 2D-arrangements required significant labour resources that 
would be challenging. Development of an automated TLD reader compatible with such a 
detector should be considered for future work to help with the establishment of a high 
resolution 2D passive dosimetry system.  
Currently there is no commercially available high resolution in-vivo dosimetry system which 
could provide a dose profile of adjacent organs at risk and also provide the possibility to 
perform non-invasive individual patient dosimetry; for example providing a dose profile of 
the oesophagus when a patient receives lung radiotherapy treatment or dose evaluation for the 
rectum or bladder in the case of prostate treatment. Technical and cost constraints being the 
challenges ahead to produce such a dosimetry system especially if disposable usage is 
intended. The physical shape of glass beads, low cost and its inert nature in addition to 
favourable dosimetric properties has led to the conceptual design of a flexible 2D in-vivo TL 
dosimetry system which could tackle the above mentioned challenges. This innovative idea 
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has won a UKTI SIRIUS programme grant and ICURe Award. The Sirius programme 
provides talented graduate entrepreneurs with an opportunity to win a place at a leading UK 
business accelerator, to obtain mentoring, financial support, help with scaling their business, 
receiving investments and gaining clients, and the possibility of a visa endorsement. The 
ICURe Innovation-to-Commercialisation programme, piloted by the SETsquared Partnership 
[representing the Universities of Surrey, Bath, Bristol, Exeter and Southampton] and funded 
by Innovate UK and Higher Education Funding Council for England (HEFCE), offers 
university researchers with commercially-promising ideas to ‘get out of the lab’ and validate 
their ideas in the marketplace. Both programmes have just started and are also planned as 
future work after completion of this PhD research programme. The project has also attracted 
the attention of the Royal Society of Medicine (RSM) and I was invited to give a presentation 
at the RSM Medical Innovations Summit that was held in London on Saturday 18
th
 April 
2015.  
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Appendix 1: 
Glass beads introductory document for 
the dosimetry audit 
Aim: 
Feasibility study of using a low cost commercially available glass beads as thermo- 
luminescence dosimeters (TLD) for postal dosimetry audit. 
Benefits 
The characteristics of a glass bead dosimeter were investigated for its potential use as a tool 
for postal dose audits. Results were compared to those of commercially available TLDs 
which have been the major tool for postal dose audits worldwide. The dosimetric 
characteristics of the glass bead dosimeter were equivalent or superior to those of the TLD 
for radiotherapy applications: 
 Smaller size (1-3 mm)  
 lower fading effect (10% / 1 month)   
 Excellent mean reproducibility of 0.23% (2SD) for a batch of 138 dosimeter  
 Higher batch homogeneity of within 5%  
 Excellent linearity with an R2 correlation coefficient of >0.999 
 Wider dose range response from 1 cGy to kGy 
 Robust to handling in room temperature and humidity 
 Chemically inert, therefore capable of in-vivo dosimetry 
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Appendix 2: 
SABR Audit; Glass Beads Irradiation 
Record Form 
 
Name of hospital: ____________________________________________ 
Local Hospital Staff: _______________ _____________  _________  _____  
Glass beads Measurements: 
 There must be1 stem and 3 holders in this package with the glass beads loaded in, which are 
the same shape as the alanine holders. Please perform two measurements according to the 
following instruction and record the holder code in the table 1. The remaining holder is spare 
in case if required. 
Table 1: Radiation record table for the glass bead inserts 
Insert No. Dose Number of MUs Date/Time 
    
    
    
 
1.  Once you have made the farmer ion chamber measurement to check the radiotherapy 
machine output, please remove the farmer chamber and without moving the setup, 
replace with the glass bead holder. Deliver 10 Gy dose for the Reference. 
2. Once you have made the farmer ion chamber measurement to check setup for the 
SABR plan, please remove the farmer chamber and without moving the phantom, 
replace with the glass bead holder. Deliver one fraction of the SABR plan (e.g. an 
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11Gy fraction). Remove the glass bead holder and then continue to set up the 
phantom for the film and alanine following the instructions. 
Note: Please place the glass bead holders immediately after irradiation in its black box 
because the light exposure to the TLD material increases the fading effect. 
Return to the University of Surrey 
 Please advise researcher (s.jafari@surrey.ac.uk , contact number: 07586808769) when 
you plan to return the irradiated glass beads, holders and stems 
 The rod and glass beads holders should be returned marked “Fragile” with plenty of 
padding (e.g. bubble wrap and padded envelope or box). 
The address to return the glass bead to is: 
Shakardokht Jafari 
20BB03 
University of Surrey 
Guildford 
Surrey 
GU2 7XH 
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